#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=Machine learning: assessing neurovascular signals in the prefrontal cortex with non-invasive bimodal electro-optical neuroimaging in opiate addiction Chronic and recurrent opiate use injuries brain tissue and cause serious pathophysiological changes in hemodynamic and subsequent inflammatory responses.
1-1	0-7	Machine	_
1-2	8-16	learning	_
1-3	17-18	:	_
1-4	19-28	assessing	_
1-5	29-42	neurovascular	_
1-6	43-50	signals	_
1-7	51-53	in	_
1-8	54-57	the	_
1-9	58-68	prefrontal	_
1-10	69-75	cortex	_
1-11	76-80	with	_
1-12	81-93	non-invasive	_
1-13	94-101	bimodal	_
1-14	102-117	electro-optical	_
1-15	118-130	neuroimaging	_
1-16	131-133	in	_
1-17	134-140	opiate	http://maven.renci.org/NeuroBridge/neurobridge#AddictionSeverityIndex
1-18	141-150	addiction	http://maven.renci.org/NeuroBridge/neurobridge#AddictionSeverityIndex
1-19	151-158	Chronic	_
1-20	159-162	and	_
1-21	163-172	recurrent	_
1-22	173-179	opiate	_
1-23	180-183	use	_
1-24	184-192	injuries	_
1-25	193-198	brain	_
1-26	199-205	tissue	_
1-27	206-209	and	_
1-28	210-215	cause	_
1-29	216-223	serious	_
1-30	224-242	pathophysiological	_
1-31	243-250	changes	_
1-32	251-253	in	_
1-33	254-265	hemodynamic	_
1-34	266-269	and	_
1-35	270-280	subsequent	_
1-36	281-293	inflammatory	_
1-37	294-303	responses	_
1-38	304-305	.	_

Text=Prefrontal cortex (PFC) has been implicated in drug addiction.
2-1	306-316	Prefrontal	_
2-2	317-323	cortex	_
2-3	324-325	(	_
2-4	326-329	PFC	_
2-5	330-331	)	_
2-6	332-335	has	_
2-7	336-340	been	_
2-8	341-351	implicated	_
2-9	352-354	in	_
2-10	355-359	drug	_
2-11	360-369	addiction	_
2-12	370-371	.	_

Text=However, the mechanism underlying systems-level neuroadaptations in PFC during abstinence has not been fully characterized.
3-1	372-379	However	_
3-2	380-381	,	_
3-3	382-385	the	_
3-4	386-395	mechanism	_
3-5	396-406	underlying	_
3-6	407-420	systems-level	_
3-7	421-437	neuroadaptations	_
3-8	438-440	in	_
3-9	441-444	PFC	_
3-10	445-451	during	_
3-11	452-462	abstinence	_
3-12	463-466	has	_
3-13	467-470	not	_
3-14	471-475	been	_
3-15	476-481	fully	_
3-16	482-495	characterized	_
3-17	496-497	.	_

Text=The objective of our study was to determine what neural oscillatory activity contributes to the chronic effect of opiate exposure and whether the activity could be coupled to neurovascular information in the PFC.
4-1	498-501	The	_
4-2	502-511	objective	_
4-3	512-514	of	_
4-4	515-518	our	_
4-5	519-524	study	_
4-6	525-528	was	_
4-7	529-531	to	_
4-8	532-541	determine	_
4-9	542-546	what	_
4-10	547-553	neural	_
4-11	554-565	oscillatory	_
4-12	566-574	activity	_
4-13	575-586	contributes	_
4-14	587-589	to	_
4-15	590-593	the	_
4-16	594-601	chronic	_
4-17	602-608	effect	_
4-18	609-611	of	_
4-19	612-618	opiate	_
4-20	619-627	exposure	_
4-21	628-631	and	_
4-22	632-639	whether	_
4-23	640-643	the	_
4-24	644-652	activity	_
4-25	653-658	could	_
4-26	659-661	be	_
4-27	662-669	coupled	_
4-28	670-672	to	_
4-29	673-686	neurovascular	_
4-30	687-698	information	_
4-31	699-701	in	_
4-32	702-705	the	_
4-33	706-709	PFC	_
4-34	710-711	.	_

Text=We employed resting-state functional connectivity to explore alterations in 8 patients with heroin dependency who stayed abstinent (> 3 months; HD) compared with 11 control subjects.
5-1	712-714	We	_
5-2	715-723	employed	_
5-3	724-737	resting-state	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-4	738-748	functional	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-5	749-761	connectivity	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
5-6	762-764	to	_
5-7	765-772	explore	_
5-8	773-784	alterations	_
5-9	785-787	in	_
5-10	788-789	8	_
5-11	790-798	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-12	799-803	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-13	804-810	heroin	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-14	811-821	dependency	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
5-15	822-825	who	_
5-16	826-832	stayed	_
5-17	833-842	abstinent	_
5-18	843-844	(	_
5-19	845-846	>	_
5-20	847-848	3	_
5-21	849-855	months	_
5-22	856-857	;	_
5-23	858-860	HD	_
5-24	861-862	)	_
5-25	863-871	compared	_
5-26	872-876	with	_
5-27	877-879	11	_
5-28	880-887	control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-29	888-896	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
5-30	897-898	.	_

Text=A non-invasive neuroimaging strategy was applied to combine electrophysiological signals through electroencephalography (EEG) with hemodynamic signals through functional near-infrared spectroscopy (fNIRS).
6-1	899-900	A	_
6-2	901-913	non-invasive	_
6-3	914-926	neuroimaging	_
6-4	927-935	strategy	_
6-5	936-939	was	_
6-6	940-947	applied	_
6-7	948-950	to	_
6-8	951-958	combine	_
6-9	959-979	electrophysiological	_
6-10	980-987	signals	_
6-11	988-995	through	_
6-12	996-1018	electroencephalography	_
6-13	1019-1020	(	_
6-14	1021-1024	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Thing
6-15	1025-1026	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
6-16	1027-1031	with	_
6-17	1032-1043	hemodynamic	_
6-18	1044-1051	signals	_
6-19	1052-1059	through	_
6-20	1060-1070	functional	_
6-21	1071-1084	near-infrared	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
6-22	1085-1097	spectroscopy	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
6-23	1098-1099	(	_
6-24	1100-1105	fNIRS	_
6-25	1106-1107	)	_
6-26	1108-1109	.	_

Text=The electrophysiological signals indicate neural synchrony and the oscillatory activity, and the hemodynamic signals indicate blood oxygenation in small vessels in the PFC.
7-1	1110-1113	The	_
7-2	1114-1134	electrophysiological	_
7-3	1135-1142	signals	_
7-4	1143-1151	indicate	_
7-5	1152-1158	neural	_
7-6	1159-1168	synchrony	_
7-7	1169-1172	and	_
7-8	1173-1176	the	_
7-9	1177-1188	oscillatory	_
7-10	1189-1197	activity	_
7-11	1198-1199	,	_
7-12	1200-1203	and	_
7-13	1204-1207	the	_
7-14	1208-1219	hemodynamic	_
7-15	1220-1227	signals	_
7-16	1228-1236	indicate	_
7-17	1237-1242	blood	_
7-18	1243-1254	oxygenation	_
7-19	1255-1257	in	_
7-20	1258-1263	small	_
7-21	1264-1271	vessels	_
7-22	1272-1274	in	_
7-23	1275-1278	the	_
7-24	1279-1282	PFC	_
7-25	1283-1284	.	_

Text=A supervised machine learning method was used to obtain associations between EEG and fNIRS modalities to improve precision and localization.
8-1	1285-1286	A	_
8-2	1287-1297	supervised	_
8-3	1298-1305	machine	_
8-4	1306-1314	learning	_
8-5	1315-1321	method	_
8-6	1322-1325	was	_
8-7	1326-1330	used	_
8-8	1331-1333	to	_
8-9	1334-1340	obtain	_
8-10	1341-1353	associations	_
8-11	1354-1361	between	_
8-12	1362-1365	EEG	_
8-13	1366-1369	and	_
8-14	1370-1375	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
8-15	1376-1386	modalities	_
8-16	1387-1389	to	_
8-17	1390-1397	improve	_
8-18	1398-1407	precision	_
8-19	1408-1411	and	_
8-20	1412-1424	localization	_
8-21	1425-1426	.	_

Text=HD patients demonstrated desynchronized lower alpha rhythms and decreased connectivity in PFC networks.
9-1	1427-1429	HD	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-2	1430-1438	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-3	1439-1451	demonstrated	_
9-4	1452-1466	desynchronized	_
9-5	1467-1472	lower	_
9-6	1473-1478	alpha	_
9-7	1479-1486	rhythms	_
9-8	1487-1490	and	_
9-9	1491-1500	decreased	_
9-10	1501-1513	connectivity	_
9-11	1514-1516	in	_
9-12	1517-1520	PFC	_
9-13	1521-1529	networks	_
9-14	1530-1531	.	_

Text=Asymmetric excitability and cerebrovascular injury were also observed.
10-1	1532-1542	Asymmetric	_
10-2	1543-1555	excitability	_
10-3	1556-1559	and	_
10-4	1560-1575	cerebrovascular	_
10-5	1576-1582	injury	_
10-6	1583-1587	were	_
10-7	1588-1592	also	_
10-8	1593-1601	observed	_
10-9	1602-1603	.	_

Text=This pilot study suggests that cerebrovascular injury in PFC may result from chronic opiate intake.
11-1	1604-1608	This	_
11-2	1609-1614	pilot	_
11-3	1615-1620	study	_
11-4	1621-1629	suggests	_
11-5	1630-1634	that	_
11-6	1635-1650	cerebrovascular	_
11-7	1651-1657	injury	_
11-8	1658-1660	in	_
11-9	1661-1664	PFC	_
11-10	1665-1668	may	_
11-11	1669-1675	result	_
11-12	1676-1680	from	_
11-13	1681-1688	chronic	_
11-14	1689-1695	opiate	_
11-15	1696-1702	intake	_
11-16	1703-1704	.	_

Text=Materials and Methods Study design This study focuses on heroin-dependent patients (HD) who had exposed to heroin for over 20 years and who managed to stay abstinent for at least three months.
12-1	1705-1714	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-2	1715-1718	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-3	1719-1726	Methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
12-4	1727-1732	Study	_
12-5	1733-1739	design	_
12-6	1740-1744	This	_
12-7	1745-1750	study	_
12-8	1751-1758	focuses	_
12-9	1759-1761	on	_
12-10	1762-1778	heroin-dependent	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
12-11	1779-1787	patients	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
12-12	1788-1789	(	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
12-13	1790-1792	HD	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
12-14	1793-1794	)	http://maven.renci.org/NeuroBridge/neurobridge#DrugDependence
12-15	1795-1798	who	_
12-16	1799-1802	had	_
12-17	1803-1810	exposed	_
12-18	1811-1813	to	_
12-19	1814-1820	heroin	_
12-20	1821-1824	for	_
12-21	1825-1829	over	_
12-22	1830-1832	20	_
12-23	1833-1838	years	_
12-24	1839-1842	and	_
12-25	1843-1846	who	_
12-26	1847-1854	managed	_
12-27	1855-1857	to	_
12-28	1858-1862	stay	_
12-29	1863-1872	abstinent	_
12-30	1873-1876	for	_
12-31	1877-1879	at	_
12-32	1880-1885	least	_
12-33	1886-1891	three	_
12-34	1892-1898	months	_
12-35	1899-1900	.	_

Text=They were compared with the healthy subjects in control group (CG) enrolled with demography matching the recruited HD patients with age, education level, and IQ (Fig.
13-1	1901-1905	They	_
13-2	1906-1910	were	_
13-3	1911-1919	compared	_
13-4	1920-1924	with	_
13-5	1925-1928	the	_
13-6	1929-1936	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-7	1937-1945	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-8	1946-1948	in	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
13-9	1949-1956	control	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
13-10	1957-1962	group	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
13-11	1963-1964	(	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
13-12	1965-1967	CG	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
13-13	1968-1969	)	http://maven.renci.org/NeuroBridge/neurobridge#ControlSubject
13-14	1970-1978	enrolled	_
13-15	1979-1983	with	_
13-16	1984-1994	demography	_
13-17	1995-2003	matching	_
13-18	2004-2007	the	_
13-19	2008-2017	recruited	_
13-20	2018-2020	HD	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-21	2021-2029	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
13-22	2030-2034	with	_
13-23	2035-2038	age	_
13-24	2039-2040	,	_
13-25	2041-2050	education	_
13-26	2051-2056	level	_
13-27	2057-2058	,	_
13-28	2059-2062	and	_
13-29	2063-2065	IQ	_
13-30	2066-2067	(	_
13-31	2068-2071	Fig	_
13-32	2072-2073	.	_

Text=1A).
14-1	2074-2076	1A	_
14-2	2077-2078	)	_
14-3	2079-2080	.	_

Text=This is an exploratory study to assess the resting-state neural synchrony, electrical oscillations, the cerebrovascular effect, and the functional connectivity of HD patients after protracted abstinence.
15-1	2081-2085	This	_
15-2	2086-2088	is	_
15-3	2089-2091	an	_
15-4	2092-2103	exploratory	_
15-5	2104-2109	study	_
15-6	2110-2112	to	_
15-7	2113-2119	assess	_
15-8	2120-2123	the	_
15-9	2124-2137	resting-state	_
15-10	2138-2144	neural	_
15-11	2145-2154	synchrony	_
15-12	2155-2156	,	_
15-13	2157-2167	electrical	_
15-14	2168-2180	oscillations	_
15-15	2181-2182	,	_
15-16	2183-2186	the	_
15-17	2187-2202	cerebrovascular	_
15-18	2203-2209	effect	_
15-19	2210-2211	,	_
15-20	2212-2215	and	_
15-21	2216-2219	the	_
15-22	2220-2230	functional	_
15-23	2231-2243	connectivity	_
15-24	2244-2246	of	_
15-25	2247-2249	HD	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-26	2250-2258	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
15-27	2259-2264	after	_
15-28	2265-2275	protracted	_
15-29	2276-2286	abstinence	_
15-30	2287-2288	.	_

Text=This study is based on the assumption that neuronal activity is generated by electrical field and greatly relies on the neurovascular coupling mechanism.
16-1	2289-2293	This	_
16-2	2294-2299	study	_
16-3	2300-2302	is	_
16-4	2303-2308	based	_
16-5	2309-2311	on	_
16-6	2312-2315	the	_
16-7	2316-2326	assumption	_
16-8	2327-2331	that	_
16-9	2332-2340	neuronal	_
16-10	2341-2349	activity	_
16-11	2350-2352	is	_
16-12	2353-2362	generated	_
16-13	2363-2365	by	_
16-14	2366-2376	electrical	_
16-15	2377-2382	field	_
16-16	2383-2386	and	_
16-17	2387-2394	greatly	_
16-18	2395-2401	relies	_
16-19	2402-2404	on	_
16-20	2405-2408	the	_
16-21	2409-2422	neurovascular	_
16-22	2423-2431	coupling	_
16-23	2432-2441	mechanism	_
16-24	2442-2443	.	_

Text=Hence, through modern machine learning method, the study is to design to examine neurophysiological information in the PFC in opiate addiction during abstinence through electrophysiological and neurovascular neuroimaging techniques.
17-1	2444-2449	Hence	_
17-2	2450-2451	,	_
17-3	2452-2459	through	_
17-4	2460-2466	modern	_
17-5	2467-2474	machine	_
17-6	2475-2483	learning	_
17-7	2484-2490	method	_
17-8	2491-2492	,	_
17-9	2493-2496	the	_
17-10	2497-2502	study	_
17-11	2503-2505	is	_
17-12	2506-2508	to	_
17-13	2509-2515	design	_
17-14	2516-2518	to	_
17-15	2519-2526	examine	_
17-16	2527-2545	neurophysiological	_
17-17	2546-2557	information	_
17-18	2558-2560	in	_
17-19	2561-2564	the	_
17-20	2565-2568	PFC	_
17-21	2569-2571	in	_
17-22	2572-2578	opiate	_
17-23	2579-2588	addiction	_
17-24	2589-2595	during	_
17-25	2596-2606	abstinence	_
17-26	2607-2614	through	_
17-27	2615-2635	electrophysiological	_
17-28	2636-2639	and	_
17-29	2640-2653	neurovascular	_
17-30	2654-2666	neuroimaging	_
17-31	2667-2677	techniques	_
17-32	2678-2679	.	_

Text=The work flows of EEG and fNIRS data processing analyses are showed in Fig.
18-1	2680-2683	The	_
18-2	2684-2688	work	_
18-3	2689-2694	flows	_
18-4	2695-2697	of	_
18-5	2698-2701	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
18-6	2702-2705	and	_
18-7	2706-2711	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
18-8	2712-2716	data	_
18-9	2717-2727	processing	_
18-10	2728-2736	analyses	_
18-11	2737-2740	are	_
18-12	2741-2747	showed	_
18-13	2748-2750	in	_
18-14	2751-2754	Fig	_
18-15	2755-2756	.	_

Text=1B.
19-1	2757-2759	1B	_
19-2	2760-2761	.	_

Text=Study subjects HD patients were eligible if they were diagnosed of OUD by a physician, had a history of at-least-20-years of recurrent heroin use, stayed abstinent for at least 3 months by the time of the study and were righted-handed between 39 and 57 years old.
20-1	2762-2767	Study	_
20-2	2768-2776	subjects	_
20-3	2777-2779	HD	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-4	2780-2788	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
20-5	2789-2793	were	_
20-6	2794-2802	eligible	_
20-7	2803-2805	if	_
20-8	2806-2810	they	_
20-9	2811-2815	were	_
20-10	2816-2825	diagnosed	_
20-11	2826-2828	of	_
20-12	2829-2832	OUD	http://maven.renci.org/NeuroBridge/neurobridge#OpioidAbuse
20-13	2833-2835	by	_
20-14	2836-2837	a	_
20-15	2838-2847	physician	_
20-16	2848-2849	,	_
20-17	2850-2853	had	_
20-18	2854-2855	a	_
20-19	2856-2863	history	_
20-20	2864-2866	of	_
20-21	2867-2884	at-least-20-years	_
20-22	2885-2887	of	_
20-23	2888-2897	recurrent	_
20-24	2898-2904	heroin	_
20-25	2905-2908	use	_
20-26	2909-2910	,	_
20-27	2911-2917	stayed	_
20-28	2918-2927	abstinent	_
20-29	2928-2931	for	_
20-30	2932-2934	at	_
20-31	2935-2940	least	_
20-32	2941-2942	3	_
20-33	2943-2949	months	_
20-34	2950-2952	by	_
20-35	2953-2956	the	_
20-36	2957-2961	time	_
20-37	2962-2964	of	_
20-38	2965-2968	the	_
20-39	2969-2974	study	_
20-40	2975-2978	and	_
20-41	2979-2983	were	_
20-42	2984-2998	righted-handed	_
20-43	2999-3006	between	_
20-44	3007-3009	39	_
20-45	3010-3013	and	_
20-46	3014-3016	57	_
20-47	3017-3022	years	_
20-48	3023-3026	old	_
20-49	3027-3028	.	_

Text=Control subjects were enrolled with demographic factors (i.e., age, education level, and IQ) matching the recruited HD patients (Fig.
21-1	3029-3036	Control	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-2	3037-3045	subjects	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-3	3046-3050	were	_
21-4	3051-3059	enrolled	_
21-5	3060-3064	with	_
21-6	3065-3076	demographic	_
21-7	3077-3084	factors	_
21-8	3085-3086	(	_
21-9	3087-3091	i.e.	_
21-10	3092-3093	,	_
21-11	3094-3097	age	_
21-12	3098-3099	,	_
21-13	3100-3109	education	_
21-14	3110-3115	level	_
21-15	3116-3117	,	_
21-16	3118-3121	and	_
21-17	3122-3124	IQ	_
21-18	3125-3126	)	_
21-19	3127-3135	matching	_
21-20	3136-3139	the	_
21-21	3140-3149	recruited	_
21-22	3150-3152	HD	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
21-23	3153-3161	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
21-24	3162-3163	(	_
21-25	3164-3167	Fig	_
21-26	3168-3169	.	_

Text=1A).
22-1	3170-3172	1A	_
22-2	3173-3174	)	_
22-3	3175-3176	.	_

Text=Prior to inclusion in the study, all enrolled subjects were required to complete a preclinical interview and collect a urine sample for urinalysis.
23-1	3177-3182	Prior	_
23-2	3183-3185	to	_
23-3	3186-3195	inclusion	_
23-4	3196-3198	in	_
23-5	3199-3202	the	_
23-6	3203-3208	study	_
23-7	3209-3210	,	_
23-8	3211-3214	all	_
23-9	3215-3223	enrolled	_
23-10	3224-3232	subjects	_
23-11	3233-3237	were	_
23-12	3238-3246	required	_
23-13	3247-3249	to	_
23-14	3250-3258	complete	_
23-15	3259-3260	a	_
23-16	3261-3272	preclinical	_
23-17	3273-3282	interview	_
23-18	3283-3286	and	_
23-19	3287-3294	collect	_
23-20	3295-3296	a	_
23-21	3297-3302	urine	_
23-22	3303-3309	sample	_
23-23	3310-3313	for	_
23-24	3314-3324	urinalysis	_
23-25	3325-3326	.	_

Text=The Structured Clinical Interview for DSM-IV (SCID) was administrated in the interview to verify opioid dependence and mental-state suitability for the study.
24-1	3327-3330	The	_
24-2	3331-3341	Structured	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-3	3342-3350	Clinical	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-4	3351-3360	Interview	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-5	3361-3364	for	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-6	3365-3371	DSM-IV	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-7	3372-3373	(	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-8	3374-3378	SCID	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-9	3379-3380	)	http://maven.renci.org/NeuroBridge/neurobridge#StructuredClinicalInterviewforDSMDisorders
24-10	3381-3384	was	_
24-11	3385-3398	administrated	_
24-12	3399-3401	in	_
24-13	3402-3405	the	_
24-14	3406-3415	interview	_
24-15	3416-3418	to	_
24-16	3419-3425	verify	_
24-17	3426-3432	opioid	_
24-18	3433-3443	dependence	_
24-19	3444-3447	and	_
24-20	3448-3460	mental-state	_
24-21	3461-3472	suitability	_
24-22	3473-3476	for	_
24-23	3477-3480	the	_
24-24	3481-3486	study	_
24-25	3487-3488	.	_

Text=Subjects with history of any neurological illness, head trauma, brain injury, or psychiatric disorders other than OUDs and Tabaco use disorder, and 72-hour of psychoactive substance use before any experimental measurements were excluded.
25-1	3489-3497	Subjects	_
25-2	3498-3502	with	_
25-3	3503-3510	history	_
25-4	3511-3513	of	_
25-5	3514-3517	any	_
25-6	3518-3530	neurological	_
25-7	3531-3538	illness	_
25-8	3539-3540	,	_
25-9	3541-3545	head	_
25-10	3546-3552	trauma	_
25-11	3553-3554	,	_
25-12	3555-3560	brain	_
25-13	3561-3567	injury	_
25-14	3568-3569	,	_
25-15	3570-3572	or	_
25-16	3573-3584	psychiatric	_
25-17	3585-3594	disorders	_
25-18	3595-3600	other	_
25-19	3601-3605	than	_
25-20	3606-3610	OUDs	_
25-21	3611-3614	and	_
25-22	3615-3621	Tabaco	http://maven.renci.org/NeuroBridge/neurobridge#CurrentUse
25-23	3622-3625	use	http://maven.renci.org/NeuroBridge/neurobridge#CurrentUse
25-24	3626-3634	disorder	_
25-25	3635-3636	,	_
25-26	3637-3640	and	_
25-27	3641-3648	72-hour	_
25-28	3649-3651	of	_
25-29	3652-3664	psychoactive	_
25-30	3665-3674	substance	_
25-31	3675-3678	use	_
25-32	3679-3685	before	_
25-33	3686-3689	any	_
25-34	3690-3702	experimental	_
25-35	3703-3715	measurements	_
25-36	3716-3720	were	_
25-37	3721-3729	excluded	_
25-38	3730-3731	.	_

Text=The protocol was approved by the Medical Ethics Committee of the University of Macau.
26-1	3732-3735	The	_
26-2	3736-3744	protocol	_
26-3	3745-3748	was	_
26-4	3749-3757	approved	_
26-5	3758-3760	by	_
26-6	3761-3764	the	_
26-7	3765-3772	Medical	_
26-8	3773-3779	Ethics	_
26-9	3780-3789	Committee	_
26-10	3790-3792	of	_
26-11	3793-3796	the	_
26-12	3797-3807	University	_
26-13	3808-3810	of	_
26-14	3811-3816	Macau	_
26-15	3817-3818	.	_

Text=The experiments were performed in accordance with the relevant guidelines and regulations in the latest version of the Declaration of Helsinki.
27-1	3819-3822	The	_
27-2	3823-3834	experiments	_
27-3	3835-3839	were	_
27-4	3840-3849	performed	_
27-5	3850-3852	in	_
27-6	3853-3863	accordance	_
27-7	3864-3868	with	_
27-8	3869-3872	the	_
27-9	3873-3881	relevant	_
27-10	3882-3892	guidelines	_
27-11	3893-3896	and	_
27-12	3897-3908	regulations	_
27-13	3909-3911	in	_
27-14	3912-3915	the	_
27-15	3916-3922	latest	_
27-16	3923-3930	version	_
27-17	3931-3933	of	_
27-18	3934-3937	the	_
27-19	3938-3949	Declaration	_
27-20	3950-3952	of	_
27-21	3953-3961	Helsinki	_
27-22	3962-3963	.	_

Text=Written informed consents were provide to all subjects.
28-1	3964-3971	Written	_
28-2	3972-3980	informed	_
28-3	3981-3989	consents	_
28-4	3990-3994	were	_
28-5	3995-4002	provide	_
28-6	4003-4005	to	_
28-7	4006-4009	all	_
28-8	4010-4018	subjects	_
28-9	4019-4020	.	_

Text=Subjects were introduced and instructed to sit comfortably on a chair in a quiet and dim room located at the Bioimaging Core of the Faculty of Health Sciences where the study was conducted.
29-1	4021-4029	Subjects	_
29-2	4030-4034	were	_
29-3	4035-4045	introduced	_
29-4	4046-4049	and	_
29-5	4050-4060	instructed	_
29-6	4061-4063	to	_
29-7	4064-4067	sit	_
29-8	4068-4079	comfortably	_
29-9	4080-4082	on	_
29-10	4083-4084	a	_
29-11	4085-4090	chair	_
29-12	4091-4093	in	_
29-13	4094-4095	a	_
29-14	4096-4101	quiet	_
29-15	4102-4105	and	_
29-16	4106-4109	dim	_
29-17	4110-4114	room	_
29-18	4115-4122	located	_
29-19	4123-4125	at	_
29-20	4126-4129	the	_
29-21	4130-4140	Bioimaging	_
29-22	4141-4145	Core	_
29-23	4146-4148	of	_
29-24	4149-4152	the	_
29-25	4153-4160	Faculty	_
29-26	4161-4163	of	_
29-27	4164-4170	Health	_
29-28	4171-4179	Sciences	_
29-29	4180-4185	where	_
29-30	4186-4189	the	_
29-31	4190-4195	study	_
29-32	4196-4199	was	_
29-33	4200-4209	conducted	_
29-34	4210-4211	.	_

Text=EEG and fNIRS signals in the eye-closed resting state were simultaneously and continuously recorded for 11 minutes.
30-1	4212-4215	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
30-2	4216-4219	and	_
30-3	4220-4225	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
30-4	4226-4233	signals	_
30-5	4234-4236	in	_
30-6	4237-4240	the	_
30-7	4241-4251	eye-closed	_
30-8	4252-4259	resting	_
30-9	4260-4265	state	_
30-10	4266-4270	were	_
30-11	4271-4285	simultaneously	_
30-12	4286-4289	and	_
30-13	4290-4302	continuously	_
30-14	4303-4311	recorded	_
30-15	4312-4315	for	_
30-16	4316-4318	11	_
30-17	4319-4326	minutes	_
30-18	4327-4328	.	_

Text=The first 2-minute measurements were eliminated to generate relatively steady signals and rule out potential effects of instability for analysis.
31-1	4329-4332	The	_
31-2	4333-4338	first	_
31-3	4339-4347	2-minute	_
31-4	4348-4360	measurements	_
31-5	4361-4365	were	_
31-6	4366-4376	eliminated	_
31-7	4377-4379	to	_
31-8	4380-4388	generate	_
31-9	4389-4399	relatively	_
31-10	4400-4406	steady	_
31-11	4407-4414	signals	_
31-12	4415-4418	and	_
31-13	4419-4423	rule	_
31-14	4424-4427	out	_
31-15	4428-4437	potential	_
31-16	4438-4445	effects	_
31-17	4446-4448	of	_
31-18	4449-4460	instability	_
31-19	4461-4464	for	_
31-20	4465-4473	analysis	_
31-21	4474-4475	.	_

Text=In part of Fig.
32-1	4476-4478	In	_
32-2	4479-4483	part	_
32-3	4484-4486	of	_
32-4	4487-4490	Fig	_
32-5	4491-4492	.	_

Text=1B shows the configuration of the EEG electrodes and fNIRS channels.
33-1	4493-4495	1B	_
33-2	4496-4501	shows	_
33-3	4502-4505	the	_
33-4	4506-4519	configuration	_
33-5	4520-4522	of	_
33-6	4523-4526	the	_
33-7	4527-4530	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
33-8	4531-4541	electrodes	_
33-9	4542-4545	and	_
33-10	4546-4551	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
33-11	4552-4560	channels	_
33-12	4561-4562	.	_

Text=A three-dimensional (3-D) digitizer (Polhemus Inc., Vermont) was used to complete the spatial registration of the electrode and channel locations, and thus, the MNI coordinates were obtained (see Supplementary Table S1).
34-1	4563-4564	A	_
34-2	4565-4582	three-dimensional	_
34-3	4583-4584	(	_
34-4	4585-4588	3-D	_
34-5	4589-4590	)	_
34-6	4591-4600	digitizer	_
34-7	4601-4602	(	_
34-8	4603-4611	Polhemus	_
34-9	4612-4616	Inc.	_
34-10	4617-4618	,	_
34-11	4619-4626	Vermont	_
34-12	4627-4628	)	_
34-13	4629-4632	was	_
34-14	4633-4637	used	_
34-15	4638-4640	to	_
34-16	4641-4649	complete	_
34-17	4650-4653	the	_
34-18	4654-4661	spatial	_
34-19	4662-4674	registration	_
34-20	4675-4677	of	_
34-21	4678-4681	the	_
34-22	4682-4691	electrode	_
34-23	4692-4695	and	_
34-24	4696-4703	channel	_
34-25	4704-4713	locations	_
34-26	4714-4715	,	_
34-27	4716-4719	and	_
34-28	4720-4724	thus	_
34-29	4725-4726	,	_
34-30	4727-4730	the	_
34-31	4731-4734	MNI	_
34-32	4735-4746	coordinates	_
34-33	4747-4751	were	_
34-34	4752-4760	obtained	_
34-35	4761-4762	(	_
34-36	4763-4766	see	_
34-37	4767-4780	Supplementary	_
34-38	4781-4786	Table	_
34-39	4787-4789	S1	_
34-40	4790-4791	)	_
34-41	4792-4793	.	_

Text=Electrophysiological measurements The electrical activity of manifold neurons up to large neuronal assemblies can be directly measured non-invasively with extracellular electrophysiological recordings, such as MEG or EEG, which are primarily generated by post-synaptic potentials and thus often susceptible to changes in neurotransmission secondary to neural dysfunction or neuropharmacological manipulations.
35-1	4794-4814	Electrophysiological	_
35-2	4815-4827	measurements	_
35-3	4828-4831	The	_
35-4	4832-4842	electrical	_
35-5	4843-4851	activity	_
35-6	4852-4854	of	_
35-7	4855-4863	manifold	_
35-8	4864-4871	neurons	_
35-9	4872-4874	up	_
35-10	4875-4877	to	_
35-11	4878-4883	large	_
35-12	4884-4892	neuronal	_
35-13	4893-4903	assemblies	_
35-14	4904-4907	can	_
35-15	4908-4910	be	_
35-16	4911-4919	directly	_
35-17	4920-4928	measured	_
35-18	4929-4943	non-invasively	_
35-19	4944-4948	with	_
35-20	4949-4962	extracellular	_
35-21	4963-4983	electrophysiological	_
35-22	4984-4994	recordings	_
35-23	4995-4996	,	_
35-24	4997-5001	such	_
35-25	5002-5004	as	_
35-26	5005-5008	MEG	http://maven.renci.org/NeuroBridge/neurobridge#Magnetoencephalography
35-27	5009-5011	or	_
35-28	5012-5015	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
35-29	5016-5017	,	_
35-30	5018-5023	which	_
35-31	5024-5027	are	_
35-32	5028-5037	primarily	_
35-33	5038-5047	generated	_
35-34	5048-5050	by	_
35-35	5051-5064	post-synaptic	_
35-36	5065-5075	potentials	_
35-37	5076-5079	and	_
35-38	5080-5084	thus	_
35-39	5085-5090	often	_
35-40	5091-5102	susceptible	_
35-41	5103-5105	to	_
35-42	5106-5113	changes	_
35-43	5114-5116	in	_
35-44	5117-5134	neurotransmission	_
35-45	5135-5144	secondary	_
35-46	5145-5147	to	_
35-47	5148-5154	neural	_
35-48	5155-5166	dysfunction	_
35-49	5167-5169	or	_
35-50	5170-5190	neuropharmacological	_
35-51	5191-5204	manipulations	_
35-52	5205-5206	.	_

Text=The EEG recordings were conducted on the Biosemi ActiveTwo system (Biosemi, Amsterdam, The Netherlands; sampling rate: 2048 Hz) from 64 electrodes on the International 10–20 system with a nose reference based.
36-1	5207-5210	The	_
36-2	5211-5214	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
36-3	5215-5225	recordings	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
36-4	5226-5230	were	_
36-5	5231-5240	conducted	_
36-6	5241-5243	on	_
36-7	5244-5247	the	_
36-8	5248-5255	Biosemi	_
36-9	5256-5265	ActiveTwo	http://maven.renci.org/NeuroBridge/neurobridge#Activity
36-10	5266-5272	system	_
36-11	5273-5274	(	_
36-12	5275-5282	Biosemi	_
36-13	5283-5284	,	_
36-14	5285-5294	Amsterdam	_
36-15	5295-5296	,	_
36-16	5297-5300	The	_
36-17	5301-5312	Netherlands	_
36-18	5313-5314	;	_
36-19	5315-5323	sampling	_
36-20	5324-5328	rate	_
36-21	5329-5330	:	_
36-22	5331-5335	2048	_
36-23	5336-5338	Hz	_
36-24	5339-5340	)	_
36-25	5341-5345	from	_
36-26	5346-5348	64	_
36-27	5349-5359	electrodes	_
36-28	5360-5362	on	_
36-29	5363-5366	the	_
36-30	5367-5380	International	_
36-31	5381-5386	10–20	_
36-32	5387-5393	system	_
36-33	5394-5398	with	_
36-34	5399-5400	a	_
36-35	5401-5405	nose	_
36-36	5406-5415	reference	_
36-37	5416-5421	based	_
36-38	5422-5423	.	_

Text=The horizontal and vertical electrooculogram (EOGs) were additionally acquired to oversee eye movements.
37-1	5424-5427	The	_
37-2	5428-5438	horizontal	_
37-3	5439-5442	and	_
37-4	5443-5451	vertical	_
37-5	5452-5468	electrooculogram	_
37-6	5469-5470	(	_
37-7	5471-5475	EOGs	_
37-8	5476-5477	)	_
37-9	5478-5482	were	_
37-10	5483-5495	additionally	_
37-11	5496-5504	acquired	_
37-12	5505-5507	to	_
37-13	5508-5515	oversee	_
37-14	5516-5519	eye	_
37-15	5520-5529	movements	_
37-16	5530-5531	.	_

Text=Electrode impedance was less than 10 kΩ.
38-1	5532-5541	Electrode	_
38-2	5542-5551	impedance	_
38-3	5552-5555	was	_
38-4	5556-5560	less	_
38-5	5561-5565	than	_
38-6	5566-5568	10	_
38-7	5569-5571	kΩ	_
38-8	5572-5573	.	_

Text=EEG data were preprocessed using EEGLAB (https: //sccn.ucsd.edu/eeglab).
39-1	5574-5577	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
39-2	5578-5582	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
39-3	5583-5587	were	_
39-4	5588-5600	preprocessed	_
39-5	5601-5606	using	_
39-6	5607-5613	EEGLAB	_
39-7	5614-5615	(	_
39-8	5616-5621	https	_
39-9	5622-5623	:	_
39-10	5624-5646	//sccn.ucsd.edu/eeglab	_
39-11	5647-5648	)	_
39-12	5649-5650	.	_

Text=Ocular artifacts acquired by EOGs channels were corrected in the recorded EEG data.
40-1	5651-5657	Ocular	_
40-2	5658-5667	artifacts	_
40-3	5668-5676	acquired	_
40-4	5677-5679	by	_
40-5	5680-5684	EOGs	_
40-6	5685-5693	channels	_
40-7	5694-5698	were	_
40-8	5699-5708	corrected	_
40-9	5709-5711	in	_
40-10	5712-5715	the	_
40-11	5716-5724	recorded	_
40-12	5725-5728	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
40-13	5729-5733	data	_
40-14	5734-5735	.	_

Text=The EEG data were segmented into 2-second epochs, of which with voltage exceeded ± 150 µV were excluded.
41-1	5736-5739	The	_
41-2	5740-5743	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
41-3	5744-5748	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
41-4	5749-5753	were	_
41-5	5754-5763	segmented	_
41-6	5764-5768	into	_
41-7	5769-5777	2-second	_
41-8	5778-5784	epochs	_
41-9	5785-5786	,	_
41-10	5787-5789	of	_
41-11	5790-5795	which	_
41-12	5796-5800	with	_
41-13	5801-5808	voltage	_
41-14	5809-5817	exceeded	_
41-15	5818-5819	±	_
41-16	5820-5823	150	_
41-17	5824-5826	µV	_
41-18	5827-5831	were	_
41-19	5832-5840	excluded	_
41-20	5841-5842	.	_

Text=Frequency bands of interest were filtered and classified by delta (1.5–4 Hz), theta (4–8 Hz), lower alpha (8–10 Hz), upper alpha (10–13 Hz), beta (14–30 Hz), and gamma (30–50 Hz).
42-1	5843-5852	Frequency	_
42-2	5853-5858	bands	_
42-3	5859-5861	of	_
42-4	5862-5870	interest	_
42-5	5871-5875	were	_
42-6	5876-5884	filtered	_
42-7	5885-5888	and	_
42-8	5889-5899	classified	_
42-9	5900-5902	by	_
42-10	5903-5908	delta	_
42-11	5909-5910	(	_
42-12	5911-5916	1.5–4	_
42-13	5917-5919	Hz	_
42-14	5920-5921	)	_
42-15	5922-5923	,	_
42-16	5924-5929	theta	_
42-17	5930-5931	(	_
42-18	5932-5935	4–8	_
42-19	5936-5938	Hz	_
42-20	5939-5940	)	_
42-21	5941-5942	,	_
42-22	5943-5948	lower	_
42-23	5949-5954	alpha	_
42-24	5955-5956	(	_
42-25	5957-5961	8–10	_
42-26	5962-5964	Hz	_
42-27	5965-5966	)	_
42-28	5967-5968	,	_
42-29	5969-5974	upper	_
42-30	5975-5980	alpha	_
42-31	5981-5982	(	_
42-32	5983-5988	10–13	_
42-33	5989-5991	Hz	_
42-34	5992-5993	)	_
42-35	5994-5995	,	_
42-36	5996-6000	beta	_
42-37	6001-6002	(	_
42-38	6003-6008	14–30	_
42-39	6009-6011	Hz	_
42-40	6012-6013	)	_
42-41	6014-6015	,	_
42-42	6016-6019	and	_
42-43	6020-6025	gamma	_
42-44	6026-6027	(	_
42-45	6028-6033	30–50	_
42-46	6034-6036	Hz	_
42-47	6037-6038	)	_
42-48	6039-6040	.	_

Text=Classification of alpha oscillations in lower and upper alpha frequency bands offers a narrowed range of interest.
43-1	6041-6055	Classification	_
43-2	6056-6058	of	_
43-3	6059-6064	alpha	_
43-4	6065-6077	oscillations	_
43-5	6078-6080	in	_
43-6	6081-6086	lower	_
43-7	6087-6090	and	_
43-8	6091-6096	upper	_
43-9	6097-6102	alpha	_
43-10	6103-6112	frequency	_
43-11	6113-6118	bands	_
43-12	6119-6125	offers	_
43-13	6126-6127	a	_
43-14	6128-6136	narrowed	_
43-15	6137-6142	range	_
43-16	6143-6145	of	_
43-17	6146-6154	interest	_
43-18	6155-6156	.	_

Text=EEG data were then down-sampled from 2048 to 256 Hz.
44-1	6157-6160	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
44-2	6161-6165	data	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
44-3	6166-6170	were	_
44-4	6171-6175	then	_
44-5	6176-6188	down-sampled	_
44-6	6189-6193	from	_
44-7	6194-6198	2048	_
44-8	6199-6201	to	_
44-9	6202-6205	256	_
44-10	6206-6208	Hz	_
44-11	6209-6210	.	_

Text=For each subject, the first 10 artifact-free baseline-corrected epochs (5120 samples; 20 seconds) were selected for further processing and analysis.
45-1	6211-6214	For	_
45-2	6215-6219	each	_
45-3	6220-6227	subject	_
45-4	6228-6229	,	_
45-5	6230-6233	the	_
45-6	6234-6239	first	_
45-7	6240-6242	10	_
45-8	6243-6256	artifact-free	_
45-9	6257-6275	baseline-corrected	_
45-10	6276-6282	epochs	_
45-11	6283-6284	(	_
45-12	6285-6289	5120	_
45-13	6290-6297	samples	_
45-14	6298-6299	;	_
45-15	6300-6302	20	_
45-16	6303-6310	seconds	_
45-17	6311-6312	)	_
45-18	6313-6317	were	_
45-19	6318-6326	selected	_
45-20	6327-6330	for	_
45-21	6331-6338	further	_
45-22	6339-6349	processing	_
45-23	6350-6353	and	_
45-24	6354-6362	analysis	_
45-25	6363-6364	.	_

Text=The detailed preprocessing method is documented in Kim et al .. Because neuronal oscillations have been associated practically with many aspects of cognitive function, two important and distinct temporal variables from the EEG: neural synchrony and oscillations were the subjects of investigation in the study.
46-1	6365-6368	The	_
46-2	6369-6377	detailed	_
46-3	6378-6391	preprocessing	_
46-4	6392-6398	method	_
46-5	6399-6401	is	_
46-6	6402-6412	documented	_
46-7	6413-6415	in	_
46-8	6416-6419	Kim	_
46-9	6420-6422	et	_
46-10	6423-6425	al	_
46-11	6426-6428	..	_
46-12	6429-6436	Because	_
46-13	6437-6445	neuronal	_
46-14	6446-6458	oscillations	_
46-15	6459-6463	have	_
46-16	6464-6468	been	_
46-17	6469-6479	associated	_
46-18	6480-6491	practically	_
46-19	6492-6496	with	_
46-20	6497-6501	many	_
46-21	6502-6509	aspects	_
46-22	6510-6512	of	_
46-23	6513-6522	cognitive	_
46-24	6523-6531	function	_
46-25	6532-6533	,	_
46-26	6534-6537	two	_
46-27	6538-6547	important	_
46-28	6548-6551	and	_
46-29	6552-6560	distinct	_
46-30	6561-6569	temporal	_
46-31	6570-6579	variables	_
46-32	6580-6584	from	_
46-33	6585-6588	the	_
46-34	6589-6592	EEG	_
46-35	6593-6594	:	_
46-36	6595-6601	neural	_
46-37	6602-6611	synchrony	_
46-38	6612-6615	and	_
46-39	6616-6628	oscillations	_
46-40	6629-6633	were	_
46-41	6634-6637	the	_
46-42	6638-6646	subjects	_
46-43	6647-6649	of	_
46-44	6650-6663	investigation	_
46-45	6664-6666	in	_
46-46	6667-6670	the	_
46-47	6671-6676	study	_
46-48	6677-6678	.	_

Text=Hemodynamic measurements Neurovascular activity, often known as hemodynamic activity, can be indirectly measured without exogenous contrast agents non-invasively by functional MRI or functional intrinsic optional imaging, such as fNIRS.
47-1	6679-6690	Hemodynamic	_
47-2	6691-6703	measurements	_
47-3	6704-6717	Neurovascular	_
47-4	6718-6726	activity	_
47-5	6727-6728	,	_
47-6	6729-6734	often	_
47-7	6735-6740	known	_
47-8	6741-6743	as	_
47-9	6744-6755	hemodynamic	_
47-10	6756-6764	activity	_
47-11	6765-6766	,	_
47-12	6767-6770	can	_
47-13	6771-6773	be	_
47-14	6774-6784	indirectly	_
47-15	6785-6793	measured	_
47-16	6794-6801	without	_
47-17	6802-6811	exogenous	_
47-18	6812-6820	contrast	_
47-19	6821-6827	agents	_
47-20	6828-6842	non-invasively	_
47-21	6843-6845	by	_
47-22	6846-6856	functional	_
47-23	6857-6860	MRI	_
47-24	6861-6863	or	_
47-25	6864-6874	functional	_
47-26	6875-6884	intrinsic	_
47-27	6885-6893	optional	_
47-28	6894-6901	imaging	_
47-29	6902-6903	,	_
47-30	6904-6908	such	_
47-31	6909-6911	as	_
47-32	6912-6917	fNIRS	_
47-33	6918-6919	.	_

Text=The fNIRS recordings were conducted on the NIRS Continuous Wave (CW) system (CW6 fNIRS system; TechEn Inc, Milford, MA; sampling rate: 50 Hz; bandpass range: 0.1–200 Hz), with four sources and eight detectors to generate fourteen channels on the scalp, covering the PFC.
48-1	6920-6923	The	_
48-2	6924-6929	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
48-3	6930-6940	recordings	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
48-4	6941-6945	were	_
48-5	6946-6955	conducted	_
48-6	6956-6958	on	_
48-7	6959-6962	the	_
48-8	6963-6967	NIRS	http://maven.renci.org/NeuroBridge/neurobridge#FirstEpisodePsychosis
48-9	6968-6978	Continuous	_
48-10	6979-6983	Wave	http://maven.renci.org/NeuroBridge/neurobridge#GravesDisease
48-11	6984-6985	(	http://maven.renci.org/NeuroBridge/neurobridge#GravesDisease
48-12	6986-6988	CW	http://maven.renci.org/NeuroBridge/neurobridge#GravesDisease
48-13	6989-6990	)	http://maven.renci.org/NeuroBridge/neurobridge#GravesDisease
48-14	6991-6997	system	_
48-15	6998-6999	(	_
48-16	7000-7003	CW6	_
48-17	7004-7009	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
48-18	7010-7016	system	_
48-19	7017-7018	;	_
48-20	7019-7025	TechEn	_
48-21	7026-7029	Inc	_
48-22	7030-7031	,	_
48-23	7032-7039	Milford	_
48-24	7040-7041	,	_
48-25	7042-7044	MA	_
48-26	7045-7046	;	_
48-27	7047-7055	sampling	_
48-28	7056-7060	rate	_
48-29	7061-7062	:	_
48-30	7063-7065	50	_
48-31	7066-7068	Hz	_
48-32	7069-7070	;	_
48-33	7071-7079	bandpass	_
48-34	7080-7085	range	_
48-35	7086-7087	:	_
48-36	7088-7095	0.1–200	_
48-37	7096-7098	Hz	_
48-38	7099-7100	)	_
48-39	7101-7102	,	_
48-40	7103-7107	with	_
48-41	7108-7112	four	_
48-42	7113-7120	sources	_
48-43	7121-7124	and	_
48-44	7125-7130	eight	_
48-45	7131-7140	detectors	_
48-46	7141-7143	to	_
48-47	7144-7152	generate	_
48-48	7153-7161	fourteen	_
48-49	7162-7170	channels	_
48-50	7171-7173	on	_
48-51	7174-7177	the	_
48-52	7178-7183	scalp	_
48-53	7184-7185	,	_
48-54	7186-7194	covering	_
48-55	7195-7198	the	_
48-56	7199-7202	PFC	_
48-57	7203-7204	.	_

Text=Each set of a source and detectors covered one particular PFC subregions, resulting in four ROIs: the right dlPFC, the left FP, the right FP, and the left dlPFC (see Supplementary Table S1 for details).
49-1	7205-7209	Each	_
49-2	7210-7213	set	_
49-3	7214-7216	of	_
49-4	7217-7218	a	_
49-5	7219-7225	source	_
49-6	7226-7229	and	_
49-7	7230-7239	detectors	_
49-8	7240-7247	covered	_
49-9	7248-7251	one	_
49-10	7252-7262	particular	_
49-11	7263-7266	PFC	_
49-12	7267-7277	subregions	_
49-13	7278-7279	,	_
49-14	7280-7289	resulting	_
49-15	7290-7292	in	_
49-16	7293-7297	four	_
49-17	7298-7302	ROIs	_
49-18	7303-7304	:	_
49-19	7305-7308	the	_
49-20	7309-7314	right	_
49-21	7315-7320	dlPFC	_
49-22	7321-7322	,	_
49-23	7323-7326	the	_
49-24	7327-7331	left	_
49-25	7332-7334	FP	_
49-26	7335-7336	,	_
49-27	7337-7340	the	_
49-28	7341-7346	right	_
49-29	7347-7349	FP	_
49-30	7350-7351	,	_
49-31	7352-7355	and	_
49-32	7356-7359	the	_
49-33	7360-7364	left	_
49-34	7365-7370	dlPFC	_
49-35	7371-7372	(	_
49-36	7373-7376	see	_
49-37	7377-7390	Supplementary	_
49-38	7391-7396	Table	_
49-39	7397-7399	S1	_
49-40	7400-7403	for	_
49-41	7404-7411	details	_
49-42	7412-7413	)	_
49-43	7414-7415	.	_

Text=The source-detector distance was 3 cm, measuring the neural activity of the cortex with an estimated 2.5 cm penetration depth.
50-1	7416-7419	The	_
50-2	7420-7435	source-detector	_
50-3	7436-7444	distance	_
50-4	7445-7448	was	_
50-5	7449-7450	3	_
50-6	7451-7453	cm	_
50-7	7454-7455	,	_
50-8	7456-7465	measuring	_
50-9	7466-7469	the	_
50-10	7470-7476	neural	_
50-11	7477-7485	activity	_
50-12	7486-7488	of	_
50-13	7489-7492	the	_
50-14	7493-7499	cortex	_
50-15	7500-7504	with	_
50-16	7505-7507	an	_
50-17	7508-7517	estimated	_
50-18	7518-7521	2.5	_
50-19	7522-7524	cm	_
50-20	7525-7536	penetration	_
50-21	7537-7542	depth	_
50-22	7543-7544	.	_

Text=The fNIRS monitors hemodynamic responses evoked by brain activity by using two CW lights at wavelengths of 690 nm and 830 nm - the characteristic absorption patterns in the near-infrared light, to obtain quantitative data of HbO and Hb.
51-1	7545-7548	The	_
51-2	7549-7554	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
51-3	7555-7563	monitors	_
51-4	7564-7575	hemodynamic	_
51-5	7576-7585	responses	_
51-6	7586-7592	evoked	_
51-7	7593-7595	by	_
51-8	7596-7601	brain	_
51-9	7602-7610	activity	_
51-10	7611-7613	by	_
51-11	7614-7619	using	_
51-12	7620-7623	two	_
51-13	7624-7626	CW	_
51-14	7627-7633	lights	_
51-15	7634-7636	at	_
51-16	7637-7648	wavelengths	_
51-17	7649-7651	of	_
51-18	7652-7655	690	_
51-19	7656-7658	nm	_
51-20	7659-7662	and	_
51-21	7663-7666	830	_
51-22	7667-7669	nm	_
51-23	7670-7671	-	_
51-24	7672-7675	the	_
51-25	7676-7690	characteristic	_
51-26	7691-7701	absorption	_
51-27	7702-7710	patterns	_
51-28	7711-7713	in	_
51-29	7714-7717	the	_
51-30	7718-7731	near-infrared	_
51-31	7732-7737	light	_
51-32	7738-7739	,	_
51-33	7740-7742	to	_
51-34	7743-7749	obtain	_
51-35	7750-7762	quantitative	_
51-36	7763-7767	data	_
51-37	7768-7770	of	_
51-38	7771-7774	HbO	_
51-39	7775-7778	and	_
51-40	7779-7781	Hb	_
51-41	7782-7783	.	_

Text=fNIRS data were preprocessed using Homer2 (www.homer-fnirs.org/documentation).
52-1	7784-7789	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
52-2	7790-7794	data	_
52-3	7795-7799	were	_
52-4	7800-7812	preprocessed	_
52-5	7813-7818	using	_
52-6	7819-7825	Homer2	_
52-7	7826-7827	(	_
52-8	7828-7861	www.homer-fnirs.org/documentation	_
52-9	7862-7863	)	_
52-10	7864-7865	.	_

Text=The preprocessed procedures were as follow: (1) Conversion from optical density to the changes in HbO or Hb concentration at different time points based on the modified Beer-Lambert Law; (2) Bandpass filtering (0.01 <fr <0.1 Hz); (3) Detrending; and (4) Motion correction using the spline interpolation method.
53-1	7866-7869	The	_
53-2	7870-7882	preprocessed	_
53-3	7883-7893	procedures	_
53-4	7894-7898	were	_
53-5	7899-7901	as	_
53-6	7902-7908	follow	_
53-7	7909-7910	:	_
53-8	7911-7912	(	_
53-9	7913-7914	1	_
53-10	7915-7916	)	_
53-11	7917-7927	Conversion	_
53-12	7928-7932	from	_
53-13	7933-7940	optical	_
53-14	7941-7948	density	_
53-15	7949-7951	to	_
53-16	7952-7955	the	_
53-17	7956-7963	changes	_
53-18	7964-7966	in	_
53-19	7967-7970	HbO	_
53-20	7971-7973	or	_
53-21	7974-7976	Hb	_
53-22	7977-7990	concentration	_
53-23	7991-7993	at	_
53-24	7994-8003	different	_
53-25	8004-8008	time	_
53-26	8009-8015	points	_
53-27	8016-8021	based	_
53-28	8022-8024	on	_
53-29	8025-8028	the	_
53-30	8029-8037	modified	_
53-31	8038-8050	Beer-Lambert	_
53-32	8051-8054	Law	_
53-33	8055-8056	;	_
53-34	8057-8058	(	_
53-35	8059-8060	2	_
53-36	8061-8062	)	_
53-37	8063-8071	Bandpass	_
53-38	8072-8081	filtering	_
53-39	8082-8083	(	_
53-40	8084-8088	0.01	_
53-41	8089-8090	<	_
53-42	8091-8093	fr	_
53-43	8094-8095	<	_
53-44	8096-8099	0.1	_
53-45	8100-8102	Hz	_
53-46	8103-8104	)	_
53-47	8105-8106	;	_
53-48	8107-8108	(	_
53-49	8109-8110	3	_
53-50	8111-8112	)	_
53-51	8113-8123	Detrending	_
53-52	8124-8125	;	_
53-53	8126-8129	and	_
53-54	8130-8131	(	_
53-55	8132-8133	4	_
53-56	8134-8135	)	_
53-57	8136-8142	Motion	_
53-58	8143-8153	correction	_
53-59	8154-8159	using	_
53-60	8160-8163	the	_
53-61	8164-8170	spline	_
53-62	8171-8184	interpolation	_
53-63	8185-8191	method	_
53-64	8192-8193	.	_

Text=There are two main types of noise due to poor contact between the optodes and scalp: motion artifacts and a low signal-to-noise ratio (SNR).
54-1	8194-8199	There	_
54-2	8200-8203	are	_
54-3	8204-8207	two	_
54-4	8208-8212	main	_
54-5	8213-8218	types	_
54-6	8219-8221	of	_
54-7	8222-8227	noise	_
54-8	8228-8231	due	_
54-9	8232-8234	to	_
54-10	8235-8239	poor	_
54-11	8240-8247	contact	_
54-12	8248-8255	between	_
54-13	8256-8259	the	_
54-14	8260-8267	optodes	_
54-15	8268-8271	and	_
54-16	8272-8277	scalp	_
54-17	8278-8279	:	_
54-18	8280-8286	motion	_
54-19	8287-8296	artifacts	_
54-20	8297-8300	and	_
54-21	8301-8302	a	_
54-22	8303-8306	low	_
54-23	8307-8322	signal-to-noise	_
54-24	8323-8328	ratio	_
54-25	8329-8330	(	_
54-26	8331-8334	SNR	_
54-27	8335-8336	)	_
54-28	8337-8338	.	_

Text=And thus, quality control is necessary before functional connectivity analysis.
55-1	8339-8342	And	_
55-2	8343-8347	thus	_
55-3	8348-8349	,	_
55-4	8350-8357	quality	_
55-5	8358-8365	control	_
55-6	8366-8368	is	_
55-7	8369-8378	necessary	_
55-8	8379-8385	before	_
55-9	8386-8396	functional	_
55-10	8397-8409	connectivity	_
55-11	8410-8418	analysis	_
55-12	8419-8420	.	_

Text=To reduce the motion-induced artifacts, the spline interpolation method detected the artifacts by calculating the moving standard deviation within sliding time windows in a 2-seoncd window length.
56-1	8421-8423	To	_
56-2	8424-8430	reduce	_
56-3	8431-8434	the	_
56-4	8435-8449	motion-induced	_
56-5	8450-8459	artifacts	_
56-6	8460-8461	,	_
56-7	8462-8465	the	_
56-8	8466-8472	spline	_
56-9	8473-8486	interpolation	_
56-10	8487-8493	method	_
56-11	8494-8502	detected	_
56-12	8503-8506	the	_
56-13	8507-8516	artifacts	_
56-14	8517-8519	by	_
56-15	8520-8531	calculating	_
56-16	8532-8535	the	_
56-17	8536-8542	moving	_
56-18	8543-8551	standard	_
56-19	8552-8561	deviation	_
56-20	8562-8568	within	_
56-21	8569-8576	sliding	_
56-22	8577-8581	time	_
56-23	8582-8589	windows	_
56-24	8590-8592	in	_
56-25	8593-8594	a	_
56-26	8595-8603	2-seoncd	_
56-27	8604-8610	window	_
56-28	8611-8617	length	_
56-29	8618-8619	.	_

Text=Any data with average signal intensity over five standard deviations of the HbO and Hb concentrations over time are considered low SNRs and thus should be excluded.
57-1	8620-8623	Any	_
57-2	8624-8628	data	_
57-3	8629-8633	with	_
57-4	8634-8641	average	_
57-5	8642-8648	signal	_
57-6	8649-8658	intensity	_
57-7	8659-8663	over	_
57-8	8664-8668	five	_
57-9	8669-8677	standard	_
57-10	8678-8688	deviations	_
57-11	8689-8691	of	_
57-12	8692-8695	the	_
57-13	8696-8699	HbO	_
57-14	8700-8703	and	_
57-15	8704-8706	Hb	_
57-16	8707-8721	concentrations	_
57-17	8722-8726	over	_
57-18	8727-8731	time	_
57-19	8732-8735	are	_
57-20	8736-8746	considered	_
57-21	8747-8750	low	_
57-22	8751-8755	SNRs	_
57-23	8756-8759	and	_
57-24	8760-8764	thus	_
57-25	8765-8771	should	_
57-26	8772-8774	be	_
57-27	8775-8783	excluded	_
57-28	8784-8785	.	_

Text=The detailed preprocessing method is documented in Niu et al .. No channel was excluded due to poor contact.
58-1	8786-8789	The	_
58-2	8790-8798	detailed	_
58-3	8799-8812	preprocessing	_
58-4	8813-8819	method	_
58-5	8820-8822	is	_
58-6	8823-8833	documented	_
58-7	8834-8836	in	_
58-8	8837-8840	Niu	_
58-9	8841-8843	et	_
58-10	8844-8846	al	_
58-11	8847-8849	..	_
58-12	8850-8852	No	_
58-13	8853-8860	channel	_
58-14	8861-8864	was	_
58-15	8865-8873	excluded	_
58-16	8874-8877	due	_
58-17	8878-8880	to	_
58-18	8881-8885	poor	_
58-19	8886-8893	contact	_
58-20	8894-8895	.	_

Text=Changes in HbO and Hb concentrations were extracted from each channel across all subjects to visually verify if there were changes of these molecules to reflect brain functional activity (i.e., an increase in [HbO] and a decrease in [Hb] indicate typical CBO, and thus brain activation).
59-1	8896-8903	Changes	_
59-2	8904-8906	in	_
59-3	8907-8910	HbO	_
59-4	8911-8914	and	_
59-5	8915-8917	Hb	_
59-6	8918-8932	concentrations	_
59-7	8933-8937	were	_
59-8	8938-8947	extracted	_
59-9	8948-8952	from	_
59-10	8953-8957	each	_
59-11	8958-8965	channel	_
59-12	8966-8972	across	_
59-13	8973-8976	all	_
59-14	8977-8985	subjects	_
59-15	8986-8988	to	_
59-16	8989-8997	visually	_
59-17	8998-9004	verify	_
59-18	9005-9007	if	_
59-19	9008-9013	there	_
59-20	9014-9018	were	_
59-21	9019-9026	changes	_
59-22	9027-9029	of	_
59-23	9030-9035	these	_
59-24	9036-9045	molecules	_
59-25	9046-9048	to	_
59-26	9049-9056	reflect	_
59-27	9057-9062	brain	_
59-28	9063-9073	functional	_
59-29	9074-9082	activity	_
59-30	9083-9084	(	_
59-31	9085-9089	i.e.	_
59-32	9090-9091	,	_
59-33	9092-9094	an	_
59-34	9095-9103	increase	_
59-35	9104-9106	in	_
59-36	9107-9108	[	_
59-37	9109-9112	HbO	_
59-38	9113-9114	]	_
59-39	9115-9118	and	_
59-40	9119-9120	a	_
59-41	9121-9129	decrease	_
59-42	9130-9132	in	_
59-43	9133-9134	[	_
59-44	9135-9137	Hb	_
59-45	9138-9139	]	_
59-46	9140-9148	indicate	_
59-47	9149-9156	typical	_
59-48	9157-9160	CBO	_
59-49	9161-9162	,	_
59-50	9163-9166	and	_
59-51	9167-9171	thus	_
59-52	9172-9177	brain	_
59-53	9178-9188	activation	_
59-54	9189-9190	)	_
59-55	9191-9192	.	_

Text=Functional connectivity analyses Functional connectivity is a statistical dependence between the time series of measured neurophysiological signals.
60-1	9193-9203	Functional	_
60-2	9204-9216	connectivity	_
60-3	9217-9225	analyses	_
60-4	9226-9236	Functional	_
60-5	9237-9249	connectivity	_
60-6	9250-9252	is	_
60-7	9253-9254	a	_
60-8	9255-9266	statistical	_
60-9	9267-9277	dependence	_
60-10	9278-9285	between	_
60-11	9286-9289	the	_
60-12	9290-9294	time	_
60-13	9295-9301	series	_
60-14	9302-9304	of	_
60-15	9305-9313	measured	_
60-16	9314-9332	neurophysiological	_
60-17	9333-9340	signals	_
60-18	9341-9342	.	_

Text=Two points in a brain are considered functionally connected if they have synchronized or coherent dynamics.
61-1	9343-9346	Two	_
61-2	9347-9353	points	_
61-3	9354-9356	in	_
61-4	9357-9358	a	_
61-5	9359-9364	brain	_
61-6	9365-9368	are	_
61-7	9369-9379	considered	_
61-8	9380-9392	functionally	_
61-9	9393-9402	connected	_
61-10	9403-9405	if	_
61-11	9406-9410	they	_
61-12	9411-9415	have	_
61-13	9416-9428	synchronized	_
61-14	9429-9431	or	_
61-15	9432-9440	coherent	_
61-16	9441-9449	dynamics	_
61-17	9450-9451	.	_

Text=The translation of different measures in the neurophysiological signals depends on the modality of recordings being used.
62-1	9452-9455	The	_
62-2	9456-9467	translation	_
62-3	9468-9470	of	_
62-4	9471-9480	different	_
62-5	9481-9489	measures	_
62-6	9490-9492	in	_
62-7	9493-9496	the	_
62-8	9497-9515	neurophysiological	_
62-9	9516-9523	signals	_
62-10	9524-9531	depends	_
62-11	9532-9534	on	_
62-12	9535-9538	the	_
62-13	9539-9547	modality	_
62-14	9548-9550	of	_
62-15	9551-9561	recordings	_
62-16	9562-9567	being	_
62-17	9568-9572	used	_
62-18	9573-9574	.	_

Text=In this study, we used the measure of SL in electrophysiological signal on the EEG recording and the measures of change in both HbO and Hb concentrations in neurovascular signal on the fNIRS recording.
63-1	9575-9577	In	_
63-2	9578-9582	this	_
63-3	9583-9588	study	_
63-4	9589-9590	,	_
63-5	9591-9593	we	_
63-6	9594-9598	used	_
63-7	9599-9602	the	_
63-8	9603-9610	measure	_
63-9	9611-9613	of	_
63-10	9614-9616	SL	_
63-11	9617-9619	in	_
63-12	9620-9640	electrophysiological	_
63-13	9641-9647	signal	_
63-14	9648-9650	on	_
63-15	9651-9654	the	_
63-16	9655-9658	EEG	_
63-17	9659-9668	recording	_
63-18	9669-9672	and	_
63-19	9673-9676	the	_
63-20	9677-9685	measures	_
63-21	9686-9688	of	_
63-22	9689-9695	change	_
63-23	9696-9698	in	_
63-24	9699-9703	both	_
63-25	9704-9707	HbO	_
63-26	9708-9711	and	_
63-27	9712-9714	Hb	_
63-28	9715-9729	concentrations	_
63-29	9730-9732	in	_
63-30	9733-9746	neurovascular	_
63-31	9747-9753	signal	_
63-32	9754-9756	on	_
63-33	9757-9760	the	_
63-34	9761-9766	fNIRS	_
63-35	9767-9776	recording	_
63-36	9777-9778	.	_

Text=To analyze the rsFC electrophysiological signal, the temporal information from the EEG, such as synchrony, was measured by SL.
64-1	9779-9781	To	_
64-2	9782-9789	analyze	_
64-3	9790-9793	the	_
64-4	9794-9798	rsFC	_
64-5	9799-9819	electrophysiological	_
64-6	9820-9826	signal	_
64-7	9827-9828	,	_
64-8	9829-9832	the	_
64-9	9833-9841	temporal	_
64-10	9842-9853	information	_
64-11	9854-9858	from	_
64-12	9859-9862	the	_
64-13	9863-9866	EEG	_
64-14	9867-9868	,	_
64-15	9869-9873	such	_
64-16	9874-9876	as	_
64-17	9877-9886	synchrony	_
64-18	9887-9888	,	_
64-19	9889-9892	was	_
64-20	9893-9901	measured	_
64-21	9902-9904	by	_
64-22	9905-9907	SL	_
64-23	9908-9909	.	_

Text=It is a generalized synchronization approach that can detect linear and nonlinear interdependences between two signals in a given number of electrodes, especially sensitive to the long-distanced synchronization of structured oscillatory activities of across whole-brain areas.
65-1	9910-9912	It	_
65-2	9913-9915	is	_
65-3	9916-9917	a	_
65-4	9918-9929	generalized	_
65-5	9930-9945	synchronization	_
65-6	9946-9954	approach	_
65-7	9955-9959	that	_
65-8	9960-9963	can	_
65-9	9964-9970	detect	_
65-10	9971-9977	linear	_
65-11	9978-9981	and	_
65-12	9982-9991	nonlinear	_
65-13	9992-10008	interdependences	_
65-14	10009-10016	between	_
65-15	10017-10020	two	_
65-16	10021-10028	signals	_
65-17	10029-10031	in	_
65-18	10032-10033	a	_
65-19	10034-10039	given	_
65-20	10040-10046	number	_
65-21	10047-10049	of	_
65-22	10050-10060	electrodes	_
65-23	10061-10062	,	_
65-24	10063-10073	especially	_
65-25	10074-10083	sensitive	_
65-26	10084-10086	to	_
65-27	10087-10090	the	_
65-28	10091-10105	long-distanced	_
65-29	10106-10121	synchronization	_
65-30	10122-10124	of	_
65-31	10125-10135	structured	_
65-32	10136-10147	oscillatory	_
65-33	10148-10158	activities	_
65-34	10159-10161	of	_
65-35	10162-10168	across	_
65-36	10169-10180	whole-brain	_
65-37	10181-10186	areas	_
65-38	10187-10188	.	_

Text=SL in each frequency band as a measure of rsFC across time and electrode and then the functional connectivity were computed using the HERMES toolbox (http: //hermes.ctb.upm.es/).
66-1	10189-10191	SL	_
66-2	10192-10194	in	_
66-3	10195-10199	each	_
66-4	10200-10209	frequency	_
66-5	10210-10214	band	_
66-6	10215-10217	as	_
66-7	10218-10219	a	_
66-8	10220-10227	measure	_
66-9	10228-10230	of	_
66-10	10231-10235	rsFC	_
66-11	10236-10242	across	_
66-12	10243-10247	time	_
66-13	10248-10251	and	_
66-14	10252-10261	electrode	_
66-15	10262-10265	and	_
66-16	10266-10270	then	_
66-17	10271-10274	the	_
66-18	10275-10285	functional	_
66-19	10286-10298	connectivity	_
66-20	10299-10303	were	_
66-21	10304-10312	computed	_
66-22	10313-10318	using	_
66-23	10319-10322	the	_
66-24	10323-10329	HERMES	_
66-25	10330-10337	toolbox	_
66-26	10338-10339	(	_
66-27	10340-10344	http	_
66-28	10345-10346	:	_
66-29	10347-10367	//hermes.ctb.upm.es/	_
66-30	10368-10369	)	_
66-31	10370-10371	.	_

Text=SL values of each subject were then averaged across each pair nodes.
67-1	10372-10374	SL	_
67-2	10375-10381	values	_
67-3	10382-10384	of	_
67-4	10385-10389	each	_
67-5	10390-10397	subject	_
67-6	10398-10402	were	_
67-7	10403-10407	then	_
67-8	10408-10416	averaged	_
67-9	10417-10423	across	_
67-10	10424-10428	each	_
67-11	10429-10433	pair	_
67-12	10434-10439	nodes	_
67-13	10440-10441	.	_

Text=Permutation test was performed to determine the between-group difference at rest.
68-1	10442-10453	Permutation	_
68-2	10454-10458	test	_
68-3	10459-10462	was	_
68-4	10463-10472	performed	_
68-5	10473-10475	to	_
68-6	10476-10485	determine	_
68-7	10486-10489	the	_
68-8	10490-10503	between-group	_
68-9	10504-10514	difference	_
68-10	10515-10517	at	_
68-11	10518-10522	rest	_
68-12	10523-10524	.	_

Text=Mean SL was analyzed to determine which frequency band was significant between groups, and its band power would be selected for further machine learning method.
69-1	10525-10529	Mean	_
69-2	10530-10532	SL	_
69-3	10533-10536	was	_
69-4	10537-10545	analyzed	_
69-5	10546-10548	to	_
69-6	10549-10558	determine	_
69-7	10559-10564	which	_
69-8	10565-10574	frequency	_
69-9	10575-10579	band	_
69-10	10580-10583	was	_
69-11	10584-10595	significant	_
69-12	10596-10603	between	_
69-13	10604-10610	groups	_
69-14	10611-10612	,	_
69-15	10613-10616	and	_
69-16	10617-10620	its	_
69-17	10621-10625	band	_
69-18	10626-10631	power	_
69-19	10632-10637	would	_
69-20	10638-10640	be	_
69-21	10641-10649	selected	_
69-22	10650-10653	for	_
69-23	10654-10661	further	_
69-24	10662-10669	machine	_
69-25	10670-10678	learning	_
69-26	10679-10685	method	_
69-27	10686-10687	.	_

Text=Connection-wise SL was analyzed by performing CBPT for multiple comparisons not only to identify the between-group significance where the SL value in HD group was significant compared to the controls, but also to offer a powerful and intuitive nonparametric framework for statistical analysis of power spectra in what brain region.
70-1	10688-10703	Connection-wise	_
70-2	10704-10706	SL	_
70-3	10707-10710	was	_
70-4	10711-10719	analyzed	_
70-5	10720-10722	by	_
70-6	10723-10733	performing	_
70-7	10734-10738	CBPT	_
70-8	10739-10742	for	_
70-9	10743-10751	multiple	_
70-10	10752-10763	comparisons	_
70-11	10764-10767	not	_
70-12	10768-10772	only	_
70-13	10773-10775	to	_
70-14	10776-10784	identify	_
70-15	10785-10788	the	_
70-16	10789-10802	between-group	_
70-17	10803-10815	significance	_
70-18	10816-10821	where	_
70-19	10822-10825	the	_
70-20	10826-10828	SL	_
70-21	10829-10834	value	_
70-22	10835-10837	in	_
70-23	10838-10840	HD	_
70-24	10841-10846	group	_
70-25	10847-10850	was	_
70-26	10851-10862	significant	_
70-27	10863-10871	compared	_
70-28	10872-10874	to	_
70-29	10875-10878	the	_
70-30	10879-10887	controls	_
70-31	10888-10889	,	_
70-32	10890-10893	but	_
70-33	10894-10898	also	_
70-34	10899-10901	to	_
70-35	10902-10907	offer	_
70-36	10908-10909	a	_
70-37	10910-10918	powerful	_
70-38	10919-10922	and	_
70-39	10923-10932	intuitive	_
70-40	10933-10946	nonparametric	_
70-41	10947-10956	framework	_
70-42	10957-10960	for	_
70-43	10961-10972	statistical	_
70-44	10973-10981	analysis	_
70-45	10982-10984	of	_
70-46	10985-10990	power	_
70-47	10991-10998	spectra	_
70-48	10999-11001	in	_
70-49	11002-11006	what	_
70-50	11007-11012	brain	_
70-51	11013-11019	region	_
70-52	11020-11021	.	_

Text=Methodological details can be found in Nico et al ..
71-1	11022-11036	Methodological	_
71-2	11037-11044	details	_
71-3	11045-11048	can	_
71-4	11049-11051	be	_
71-5	11052-11057	found	_
71-6	11058-11060	in	_
71-7	11061-11065	Nico	_
71-8	11066-11068	et	_
71-9	11069-11071	al	_
71-10	11072-11074	..	_

Text=The electrodes corresponding to the significant brain region (i.e., source) calculated by CBPT would be selected for machine learning method.
72-1	11075-11078	The	_
72-2	11079-11089	electrodes	_
72-3	11090-11103	corresponding	_
72-4	11104-11106	to	_
72-5	11107-11110	the	_
72-6	11111-11122	significant	_
72-7	11123-11128	brain	_
72-8	11129-11135	region	_
72-9	11136-11137	(	_
72-10	11138-11142	i.e.	_
72-11	11143-11144	,	_
72-12	11145-11151	source	_
72-13	11152-11153	)	_
72-14	11154-11164	calculated	_
72-15	11165-11167	by	_
72-16	11168-11172	CBPT	_
72-17	11173-11178	would	_
72-18	11179-11181	be	_
72-19	11182-11190	selected	_
72-20	11191-11194	for	_
72-21	11195-11202	machine	_
72-22	11203-11211	learning	_
72-23	11212-11218	method	_
72-24	11219-11220	.	_

Text=To analyze the rsFC neurovascular effect, the information regarding to the changes in HbO and Hb concentrations from the fNIRS were evaluated.
73-1	11221-11223	To	_
73-2	11224-11231	analyze	_
73-3	11232-11235	the	_
73-4	11236-11240	rsFC	_
73-5	11241-11254	neurovascular	_
73-6	11255-11261	effect	_
73-7	11262-11263	,	_
73-8	11264-11267	the	_
73-9	11268-11279	information	_
73-10	11280-11289	regarding	_
73-11	11290-11292	to	_
73-12	11293-11296	the	_
73-13	11297-11304	changes	_
73-14	11305-11307	in	_
73-15	11308-11311	HbO	_
73-16	11312-11315	and	_
73-17	11316-11318	Hb	_
73-18	11319-11333	concentrations	_
73-19	11334-11338	from	_
73-20	11339-11342	the	_
73-21	11343-11348	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
73-22	11349-11353	were	_
73-23	11354-11363	evaluated	_
73-24	11364-11365	.	_

Text=Whole-brain correlation analysis was performed because it allowed us to easily observe the change of the two chromophores in a matrix and, more importantly, to compute a functional connectivity map between any two channel pairs in the PFC system, where the channels represented nodes, and where the functional connections with correlation coefficient, r, greater than a predefined threshold were considered edges.
74-1	11366-11377	Whole-brain	_
74-2	11378-11389	correlation	_
74-3	11390-11398	analysis	_
74-4	11399-11402	was	_
74-5	11403-11412	performed	_
74-6	11413-11420	because	_
74-7	11421-11423	it	_
74-8	11424-11431	allowed	_
74-9	11432-11434	us	_
74-10	11435-11437	to	_
74-11	11438-11444	easily	_
74-12	11445-11452	observe	_
74-13	11453-11456	the	_
74-14	11457-11463	change	_
74-15	11464-11466	of	_
74-16	11467-11470	the	_
74-17	11471-11474	two	_
74-18	11475-11487	chromophores	_
74-19	11488-11490	in	_
74-20	11491-11492	a	_
74-21	11493-11499	matrix	_
74-22	11500-11503	and	_
74-23	11504-11505	,	_
74-24	11506-11510	more	_
74-25	11511-11522	importantly	_
74-26	11523-11524	,	_
74-27	11525-11527	to	_
74-28	11528-11535	compute	_
74-29	11536-11537	a	_
74-30	11538-11548	functional	_
74-31	11549-11561	connectivity	_
74-32	11562-11565	map	_
74-33	11566-11573	between	_
74-34	11574-11577	any	_
74-35	11578-11581	two	_
74-36	11582-11589	channel	_
74-37	11590-11595	pairs	_
74-38	11596-11598	in	_
74-39	11599-11602	the	_
74-40	11603-11606	PFC	_
74-41	11607-11613	system	_
74-42	11614-11615	,	_
74-43	11616-11621	where	_
74-44	11622-11625	the	_
74-45	11626-11634	channels	_
74-46	11635-11646	represented	_
74-47	11647-11652	nodes	_
74-48	11653-11654	,	_
74-49	11655-11658	and	_
74-50	11659-11664	where	_
74-51	11665-11668	the	_
74-52	11669-11679	functional	_
74-53	11680-11691	connections	_
74-54	11692-11696	with	_
74-55	11697-11708	correlation	_
74-56	11709-11720	coefficient	_
74-57	11721-11722	,	_
74-58	11723-11724	r	_
74-59	11725-11726	,	_
74-60	11727-11734	greater	_
74-61	11735-11739	than	_
74-62	11740-11741	a	_
74-63	11742-11752	predefined	_
74-64	11753-11762	threshold	_
74-65	11763-11767	were	_
74-66	11768-11778	considered	_
74-67	11779-11784	edges	_
74-68	11785-11786	.	_

Text=The result of computing r for each channel of a chromophore was a 14 × 14 matrix.
75-1	11787-11790	The	_
75-2	11791-11797	result	_
75-3	11798-11800	of	_
75-4	11801-11810	computing	_
75-5	11811-11812	r	_
75-6	11813-11816	for	_
75-7	11817-11821	each	_
75-8	11822-11829	channel	_
75-9	11830-11832	of	_
75-10	11833-11834	a	_
75-11	11835-11846	chromophore	_
75-12	11847-11850	was	_
75-13	11851-11852	a	_
75-14	11853-11855	14	_
75-15	11856-11857	×	_
75-16	11858-11860	14	_
75-17	11861-11867	matrix	_
75-18	11868-11869	.	_

Text=All correlation values were converted to z-scores using the Fisher z-transformation prior to any statistical analysis.
76-1	11870-11873	All	_
76-2	11874-11885	correlation	_
76-3	11886-11892	values	_
76-4	11893-11897	were	_
76-5	11898-11907	converted	_
76-6	11908-11910	to	_
76-7	11911-11919	z-scores	_
76-8	11920-11925	using	_
76-9	11926-11929	the	_
76-10	11930-11936	Fisher	_
76-11	11937-11953	z-transformation	_
76-12	11954-11959	prior	_
76-13	11960-11962	to	_
76-14	11963-11966	any	_
76-15	11967-11978	statistical	_
76-16	11979-11987	analysis	_
76-17	11988-11989	.	_

Text=For simplicity, the concentration change in HbO was primarily analyzed and selected for further processing in the subsequent quantitative nodal network analysis as a feature for machine learning method because it is thought to be the most responsive indicator of differences in CBF and the most sensitive parameter of change in rCBO.
77-1	11990-11993	For	_
77-2	11994-12004	simplicity	_
77-3	12005-12006	,	_
77-4	12007-12010	the	_
77-5	12011-12024	concentration	_
77-6	12025-12031	change	_
77-7	12032-12034	in	_
77-8	12035-12038	HbO	_
77-9	12039-12042	was	_
77-10	12043-12052	primarily	_
77-11	12053-12061	analyzed	_
77-12	12062-12065	and	_
77-13	12066-12074	selected	_
77-14	12075-12078	for	_
77-15	12079-12086	further	_
77-16	12087-12097	processing	_
77-17	12098-12100	in	_
77-18	12101-12104	the	_
77-19	12105-12115	subsequent	_
77-20	12116-12128	quantitative	_
77-21	12129-12134	nodal	_
77-22	12135-12142	network	_
77-23	12143-12151	analysis	_
77-24	12152-12154	as	_
77-25	12155-12156	a	_
77-26	12157-12164	feature	_
77-27	12165-12168	for	_
77-28	12169-12176	machine	_
77-29	12177-12185	learning	_
77-30	12186-12192	method	_
77-31	12193-12200	because	_
77-32	12201-12203	it	_
77-33	12204-12206	is	_
77-34	12207-12214	thought	_
77-35	12215-12217	to	_
77-36	12218-12220	be	_
77-37	12221-12224	the	_
77-38	12225-12229	most	_
77-39	12230-12240	responsive	_
77-40	12241-12250	indicator	_
77-41	12251-12253	of	_
77-42	12254-12265	differences	_
77-43	12266-12268	in	_
77-44	12269-12272	CBF	_
77-45	12273-12276	and	_
77-46	12277-12280	the	_
77-47	12281-12285	most	_
77-48	12286-12295	sensitive	_
77-49	12296-12305	parameter	_
77-50	12306-12308	of	_
77-51	12309-12315	change	_
77-52	12316-12318	in	_
77-53	12319-12323	rCBO	_
77-54	12324-12325	.	_

Text=Consisting with our previous work, the threshold value was determined by the foremost 5% of the connections before generating a network topological map.
78-1	12326-12336	Consisting	_
78-2	12337-12341	with	_
78-3	12342-12345	our	_
78-4	12346-12354	previous	_
78-5	12355-12359	work	_
78-6	12360-12361	,	_
78-7	12362-12365	the	_
78-8	12366-12375	threshold	_
78-9	12376-12381	value	_
78-10	12382-12385	was	_
78-11	12386-12396	determined	_
78-12	12397-12399	by	_
78-13	12400-12403	the	_
78-14	12404-12412	foremost	_
78-15	12413-12414	5	_
78-16	12415-12416	%	_
78-17	12417-12419	of	_
78-18	12420-12423	the	_
78-19	12424-12435	connections	_
78-20	12436-12442	before	_
78-21	12443-12453	generating	_
78-22	12454-12455	a	_
78-23	12456-12463	network	_
78-24	12464-12475	topological	_
78-25	12476-12479	map	_
78-26	12480-12481	.	_

Text=For visualization, BrainNet Viewer toolbox (https: //www.nitrc.org/projects/bnv) was applied.
79-1	12482-12485	For	_
79-2	12486-12499	visualization	_
79-3	12500-12501	,	_
79-4	12502-12510	BrainNet	_
79-5	12511-12517	Viewer	_
79-6	12518-12525	toolbox	_
79-7	12526-12527	(	_
79-8	12528-12533	https	_
79-9	12534-12535	:	_
79-10	12536-12564	//www.nitrc.org/projects/bnv	_
79-11	12565-12566	)	_
79-12	12567-12570	was	_
79-13	12571-12578	applied	_
79-14	12579-12580	.	_

Text=For nodal network analysis, the degree strength of each channel was quantified by averaging connectivity of a channel in the PFC system.
80-1	12581-12584	For	_
80-2	12585-12590	nodal	_
80-3	12591-12598	network	_
80-4	12599-12607	analysis	_
80-5	12608-12609	,	_
80-6	12610-12613	the	_
80-7	12614-12620	degree	_
80-8	12621-12629	strength	_
80-9	12630-12632	of	_
80-10	12633-12637	each	_
80-11	12638-12645	channel	_
80-12	12646-12649	was	_
80-13	12650-12660	quantified	_
80-14	12661-12663	by	_
80-15	12664-12673	averaging	_
80-16	12674-12686	connectivity	_
80-17	12687-12689	of	_
80-18	12690-12691	a	_
80-19	12692-12699	channel	_
80-20	12700-12702	in	_
80-21	12703-12706	the	_
80-22	12707-12710	PFC	_
80-23	12711-12717	system	_
80-24	12718-12719	.	_

Text=Methodological details can be found in our previous work.
81-1	12720-12734	Methodological	_
81-2	12735-12742	details	_
81-3	12743-12746	can	_
81-4	12747-12749	be	_
81-5	12750-12755	found	_
81-6	12756-12758	in	_
81-7	12759-12762	our	_
81-8	12763-12771	previous	_
81-9	12772-12776	work	_
81-10	12777-12778	.	_

Text=Machine learning: multi-modal data analysis for PFC imaging One of the most modern multimodal neuroimaging setups is to combine the measurement of electrophysiology with the measurement of hemodynamics.
82-1	12779-12786	Machine	_
82-2	12787-12795	learning	_
82-3	12796-12797	:	_
82-4	12798-12809	multi-modal	_
82-5	12810-12814	data	_
82-6	12815-12823	analysis	_
82-7	12824-12827	for	_
82-8	12828-12831	PFC	_
82-9	12832-12839	imaging	_
82-10	12840-12843	One	_
82-11	12844-12846	of	_
82-12	12847-12850	the	_
82-13	12851-12855	most	_
82-14	12856-12862	modern	_
82-15	12863-12873	multimodal	_
82-16	12874-12886	neuroimaging	_
82-17	12887-12893	setups	_
82-18	12894-12896	is	_
82-19	12897-12899	to	_
82-20	12900-12907	combine	_
82-21	12908-12911	the	_
82-22	12912-12923	measurement	_
82-23	12924-12926	of	_
82-24	12927-12944	electrophysiology	_
82-25	12945-12949	with	_
82-26	12950-12953	the	_
82-27	12954-12965	measurement	_
82-28	12966-12968	of	_
82-29	12969-12981	hemodynamics	_
82-30	12982-12983	.	_

Text=Machine learning method is used to obtain correlations between EEG and fNIRS modalities by extracting physiologically plausible components.
83-1	12984-12991	Machine	_
83-2	12992-13000	learning	_
83-3	13001-13007	method	_
83-4	13008-13010	is	_
83-5	13011-13015	used	_
83-6	13016-13018	to	_
83-7	13019-13025	obtain	_
83-8	13026-13038	correlations	_
83-9	13039-13046	between	_
83-10	13047-13050	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
83-11	13051-13054	and	_
83-12	13055-13060	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
83-13	13061-13071	modalities	_
83-14	13072-13074	by	_
83-15	13075-13085	extracting	_
83-16	13086-13101	physiologically	_
83-17	13102-13111	plausible	_
83-18	13112-13122	components	_
83-19	13123-13124	.	_

Text=It is believed that the data obtained through this multimodality which otherwise offers exceptional spatial and temporal imaging resolution allows for combination of complementary information, thereby a desirable diagnosis, and a deeper understanding of how electrophysiological and neurovascular aspects of brain activity are related.
84-1	13125-13127	It	_
84-2	13128-13130	is	_
84-3	13131-13139	believed	_
84-4	13140-13144	that	_
84-5	13145-13148	the	_
84-6	13149-13153	data	_
84-7	13154-13162	obtained	_
84-8	13163-13170	through	_
84-9	13171-13175	this	_
84-10	13176-13189	multimodality	_
84-11	13190-13195	which	_
84-12	13196-13205	otherwise	_
84-13	13206-13212	offers	_
84-14	13213-13224	exceptional	_
84-15	13225-13232	spatial	_
84-16	13233-13236	and	_
84-17	13237-13245	temporal	_
84-18	13246-13253	imaging	_
84-19	13254-13264	resolution	_
84-20	13265-13271	allows	_
84-21	13272-13275	for	_
84-22	13276-13287	combination	_
84-23	13288-13290	of	_
84-24	13291-13304	complementary	_
84-25	13305-13316	information	_
84-26	13317-13318	,	_
84-27	13319-13326	thereby	_
84-28	13327-13328	a	_
84-29	13329-13338	desirable	_
84-30	13339-13348	diagnosis	_
84-31	13349-13350	,	_
84-32	13351-13354	and	_
84-33	13355-13356	a	_
84-34	13357-13363	deeper	_
84-35	13364-13377	understanding	_
84-36	13378-13380	of	_
84-37	13381-13384	how	_
84-38	13385-13405	electrophysiological	_
84-39	13406-13409	and	_
84-40	13410-13423	neurovascular	_
84-41	13424-13431	aspects	_
84-42	13432-13434	of	_
84-43	13435-13440	brain	_
84-44	13441-13449	activity	_
84-45	13450-13453	are	_
84-46	13454-13461	related	_
84-47	13462-13463	.	_

Text=To increase precision and detect minuscule signals from both of the electrophysiological and hemodynamic measurements, the mSPoC analysis was performed.
85-1	13464-13466	To	_
85-2	13467-13475	increase	_
85-3	13476-13485	precision	_
85-4	13486-13489	and	_
85-5	13490-13496	detect	_
85-6	13497-13506	minuscule	_
85-7	13507-13514	signals	_
85-8	13515-13519	from	_
85-9	13520-13524	both	_
85-10	13525-13527	of	_
85-11	13528-13531	the	_
85-12	13532-13552	electrophysiological	_
85-13	13553-13556	and	_
85-14	13557-13568	hemodynamic	_
85-15	13569-13581	measurements	_
85-16	13582-13583	,	_
85-17	13584-13587	the	_
85-18	13588-13593	mSPoC	_
85-19	13594-13602	analysis	_
85-20	13603-13606	was	_
85-21	13607-13616	performed	_
85-22	13617-13618	.	_

Text=The amplitude (i.e., band power) and the frequency of the temporal oscillation selected from the EEG-based connectivity analysis, were extracted as an EEG feature.
86-1	13619-13622	The	_
86-2	13623-13632	amplitude	_
86-3	13633-13634	(	_
86-4	13635-13639	i.e.	_
86-5	13640-13641	,	_
86-6	13642-13646	band	_
86-7	13647-13652	power	_
86-8	13653-13654	)	_
86-9	13655-13658	and	_
86-10	13659-13662	the	_
86-11	13663-13672	frequency	_
86-12	13673-13675	of	_
86-13	13676-13679	the	_
86-14	13680-13688	temporal	_
86-15	13689-13700	oscillation	_
86-16	13701-13709	selected	_
86-17	13710-13714	from	_
86-18	13715-13718	the	_
86-19	13719-13728	EEG-based	_
86-20	13729-13741	connectivity	_
86-21	13742-13750	analysis	_
86-22	13751-13752	,	_
86-23	13753-13757	were	_
86-24	13758-13767	extracted	_
86-25	13768-13770	as	_
86-26	13771-13773	an	_
86-27	13774-13777	EEG	_
86-28	13778-13785	feature	_
86-29	13786-13787	.	_

Text=In order to perform the bi-modal EEG-fNIRS fusion, the number of samples from fNIRS data must equal to the number of epoch from EEG data because the modulations of a source extracted from fNIRS is related to the modulations of the power of a source from EEG.
87-1	13788-13790	In	_
87-2	13791-13796	order	_
87-3	13797-13799	to	_
87-4	13800-13807	perform	_
87-5	13808-13811	the	_
87-6	13812-13820	bi-modal	_
87-7	13821-13830	EEG-fNIRS	_
87-8	13831-13837	fusion	_
87-9	13838-13839	,	_
87-10	13840-13843	the	_
87-11	13844-13850	number	_
87-12	13851-13853	of	_
87-13	13854-13861	samples	_
87-14	13862-13866	from	_
87-15	13867-13872	fNIRS	_
87-16	13873-13877	data	_
87-17	13878-13882	must	_
87-18	13883-13888	equal	_
87-19	13889-13891	to	_
87-20	13892-13895	the	_
87-21	13896-13902	number	_
87-22	13903-13905	of	_
87-23	13906-13911	epoch	_
87-24	13912-13916	from	_
87-25	13917-13920	EEG	_
87-26	13921-13925	data	_
87-27	13926-13933	because	_
87-28	13934-13937	the	_
87-29	13938-13949	modulations	_
87-30	13950-13952	of	_
87-31	13953-13954	a	_
87-32	13955-13961	source	_
87-33	13962-13971	extracted	_
87-34	13972-13976	from	_
87-35	13977-13982	fNIRS	_
87-36	13983-13985	is	_
87-37	13986-13993	related	_
87-38	13994-13996	to	_
87-39	13997-14000	the	_
87-40	14001-14012	modulations	_
87-41	14013-14015	of	_
87-42	14016-14019	the	_
87-43	14020-14025	power	_
87-44	14026-14028	of	_
87-45	14029-14030	a	_
87-46	14031-14037	source	_
87-47	14038-14042	from	_
87-48	14043-14046	EEG	_
87-49	14047-14048	.	_

Text=The preprocessed fNIRS data were then down-sampled from 50 to 5 Hz.
88-1	14049-14052	The	_
88-2	14053-14065	preprocessed	_
88-3	14066-14071	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
88-4	14072-14076	data	_
88-5	14077-14081	were	_
88-6	14082-14086	then	_
88-7	14087-14099	down-sampled	_
88-8	14100-14104	from	_
88-9	14105-14107	50	_
88-10	14108-14110	to	_
88-11	14111-14112	5	_
88-12	14113-14115	Hz	_
88-13	14116-14117	.	_

Text=For each subject, the first 10 HbO-based samples (i.e., [HbOf]) were extracted as a fNIRS feature (in part, Fig.
89-1	14118-14121	For	_
89-2	14122-14126	each	_
89-3	14127-14134	subject	_
89-4	14135-14136	,	_
89-5	14137-14140	the	_
89-6	14141-14146	first	_
89-7	14147-14149	10	_
89-8	14150-14159	HbO-based	_
89-9	14160-14167	samples	_
89-10	14168-14169	(	_
89-11	14170-14174	i.e.	_
89-12	14175-14176	,	_
89-13	14177-14178	[	_
89-14	14179-14183	HbOf	_
89-15	14184-14185	]	_
89-16	14186-14187	)	_
89-17	14188-14192	were	_
89-18	14193-14202	extracted	_
89-19	14203-14205	as	_
89-20	14206-14207	a	_
89-21	14208-14213	fNIRS	_
89-22	14214-14221	feature	_
89-23	14222-14223	(	_
89-24	14224-14226	in	_
89-25	14227-14231	part	_
89-26	14232-14233	,	_
89-27	14234-14237	Fig	_
89-28	14238-14239	.	_

Text=1B).
90-1	14240-14242	1B	_
90-2	14243-14244	)	_
90-3	14245-14246	.	_

Text=Both datasets were preprocessed to extract features using a sliding window of 2 seconds.
91-1	14247-14251	Both	_
91-2	14252-14260	datasets	_
91-3	14261-14265	were	_
91-4	14266-14278	preprocessed	_
91-5	14279-14281	to	_
91-6	14282-14289	extract	_
91-7	14290-14298	features	_
91-8	14299-14304	using	_
91-9	14305-14306	a	_
91-10	14307-14314	sliding	_
91-11	14315-14321	window	_
91-12	14322-14324	of	_
91-13	14325-14326	2	_
91-14	14327-14334	seconds	_
91-15	14335-14336	.	_

Text=The mSPoC method was proposed to examine the comodulation between resting-state-induced power dynamics of the selected oscillatory rhythm and changes in HbO concentration.
92-1	14337-14340	The	_
92-2	14341-14346	mSPoC	_
92-3	14347-14353	method	_
92-4	14354-14357	was	_
92-5	14358-14366	proposed	_
92-6	14367-14369	to	_
92-7	14370-14377	examine	_
92-8	14378-14381	the	_
92-9	14382-14394	comodulation	_
92-10	14395-14402	between	_
92-11	14403-14424	resting-state-induced	_
92-12	14425-14430	power	_
92-13	14431-14439	dynamics	_
92-14	14440-14442	of	_
92-15	14443-14446	the	_
92-16	14447-14455	selected	_
92-17	14456-14467	oscillatory	_
92-18	14468-14474	rhythm	_
92-19	14475-14478	and	_
92-20	14479-14486	changes	_
92-21	14487-14489	in	_
92-22	14490-14493	HbO	_
92-23	14494-14507	concentration	_
92-24	14508-14509	.	_

Text=Through this supervised machine learning strategy, it finds the direction (i.e., spatial filters) of the two class (i.e., EEG and fNIRS) in a high-dimensional space such that the spectral power dynamics of the projected electrophysiological signal (i.e., EEG-source) maximizing covaried with the time-course of the project hemodynamic signal (i.e., a corresponding fNIRS-source).
93-1	14510-14517	Through	_
93-2	14518-14522	this	_
93-3	14523-14533	supervised	_
93-4	14534-14541	machine	_
93-5	14542-14550	learning	_
93-6	14551-14559	strategy	_
93-7	14560-14561	,	_
93-8	14562-14564	it	_
93-9	14565-14570	finds	_
93-10	14571-14574	the	_
93-11	14575-14584	direction	_
93-12	14585-14586	(	_
93-13	14587-14591	i.e.	_
93-14	14592-14593	,	_
93-15	14594-14601	spatial	_
93-16	14602-14609	filters	_
93-17	14610-14611	)	_
93-18	14612-14614	of	_
93-19	14615-14618	the	_
93-20	14619-14622	two	_
93-21	14623-14628	class	_
93-22	14629-14630	(	_
93-23	14631-14635	i.e.	_
93-24	14636-14637	,	_
93-25	14638-14641	EEG	_
93-26	14642-14645	and	_
93-27	14646-14651	fNIRS	_
93-28	14652-14653	)	_
93-29	14654-14656	in	_
93-30	14657-14658	a	_
93-31	14659-14675	high-dimensional	_
93-32	14676-14681	space	_
93-33	14682-14686	such	_
93-34	14687-14691	that	_
93-35	14692-14695	the	_
93-36	14696-14704	spectral	_
93-37	14705-14710	power	_
93-38	14711-14719	dynamics	_
93-39	14720-14722	of	_
93-40	14723-14726	the	_
93-41	14727-14736	projected	_
93-42	14737-14757	electrophysiological	_
93-43	14758-14764	signal	_
93-44	14765-14766	(	_
93-45	14767-14771	i.e.	_
93-46	14772-14773	,	_
93-47	14774-14784	EEG-source	_
93-48	14785-14786	)	_
93-49	14787-14797	maximizing	_
93-50	14798-14806	covaried	_
93-51	14807-14811	with	_
93-52	14812-14815	the	_
93-53	14816-14827	time-course	_
93-54	14828-14830	of	_
93-55	14831-14834	the	_
93-56	14835-14842	project	_
93-57	14843-14854	hemodynamic	_
93-58	14855-14861	signal	_
93-59	14862-14863	(	_
93-60	14864-14868	i.e.	_
93-61	14869-14870	,	_
93-62	14871-14872	a	_
93-63	14873-14886	corresponding	_
93-64	14887-14899	fNIRS-source	_
93-65	14900-14901	)	_
93-66	14902-14903	.	_

Text=The time-invariant coupling coefficients of each source with the different sensors (i.e., the common spatial patterns) of EEG and fNIRS data were then calculated.
94-1	14904-14907	The	_
94-2	14908-14922	time-invariant	_
94-3	14923-14931	coupling	_
94-4	14932-14944	coefficients	_
94-5	14945-14947	of	_
94-6	14948-14952	each	_
94-7	14953-14959	source	_
94-8	14960-14964	with	_
94-9	14965-14968	the	_
94-10	14969-14978	different	_
94-11	14979-14986	sensors	_
94-12	14987-14988	(	_
94-13	14989-14993	i.e.	_
94-14	14994-14995	,	_
94-15	14996-14999	the	_
94-16	15000-15006	common	_
94-17	15007-15014	spatial	_
94-18	15015-15023	patterns	_
94-19	15024-15025	)	_
94-20	15026-15028	of	_
94-21	15029-15032	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
94-22	15033-15036	and	_
94-23	15037-15042	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
94-24	15043-15047	data	_
94-25	15048-15052	were	_
94-26	15053-15057	then	_
94-27	15058-15068	calculated	_
94-28	15069-15070	.	_

Text=The detailed fusion method is documented in Dähne et al ..
95-1	15071-15074	The	_
95-2	15075-15083	detailed	_
95-3	15084-15090	fusion	_
95-4	15091-15097	method	_
95-5	15098-15100	is	_
95-6	15101-15111	documented	_
95-7	15112-15114	in	_
95-8	15115-15120	Dähne	_
95-9	15121-15123	et	_
95-10	15124-15126	al	_
95-11	15127-15129	..	_

Text=The brain area generating the EEG mSPoC component was localized in the PFC subregions and across PFC region as a whole.
96-1	15130-15133	The	_
96-2	15134-15139	brain	_
96-3	15140-15144	area	_
96-4	15145-15155	generating	_
96-5	15156-15159	the	_
96-6	15160-15163	EEG	_
96-7	15164-15169	mSPoC	_
96-8	15170-15179	component	_
96-9	15180-15183	was	_
96-10	15184-15193	localized	_
96-11	15194-15196	in	_
96-12	15197-15200	the	_
96-13	15201-15204	PFC	_
96-14	15205-15215	subregions	_
96-15	15216-15219	and	_
96-16	15220-15226	across	_
96-17	15227-15230	PFC	_
96-18	15231-15237	region	_
96-19	15238-15240	as	_
96-20	15241-15242	a	_
96-21	15243-15248	whole	_
96-22	15249-15250	.	_

Text=The EEG mSPoC component which has the greatest coupling coefficient value was then selected to fuse with the corresponding fNIRS component.
97-1	15251-15254	The	_
97-2	15255-15258	EEG	_
97-3	15259-15264	mSPoC	_
97-4	15265-15274	component	_
97-5	15275-15280	which	_
97-6	15281-15284	has	_
97-7	15285-15288	the	_
97-8	15289-15297	greatest	_
97-9	15298-15306	coupling	_
97-10	15307-15318	coefficient	_
97-11	15319-15324	value	_
97-12	15325-15328	was	_
97-13	15329-15333	then	_
97-14	15334-15342	selected	_
97-15	15343-15345	to	_
97-16	15346-15350	fuse	_
97-17	15351-15355	with	_
97-18	15356-15359	the	_
97-19	15360-15373	corresponding	_
97-20	15374-15379	fNIRS	_
97-21	15380-15389	component	_
97-22	15390-15391	.	_

Text=In addition to mSPoC analysis, sensor-space cortical source estimation was separately performed for both EEG and fNIRS datasets by using the eConnectome toolbox (http: //econnectome.umn.edu/) and the NIRS-SPM toolbox (http: //bispl.weebly.com/nirs-spm.html #/), respectively, to visually scan through activation locations.
98-1	15392-15394	In	_
98-2	15395-15403	addition	_
98-3	15404-15406	to	_
98-4	15407-15412	mSPoC	_
98-5	15413-15421	analysis	_
98-6	15422-15423	,	_
98-7	15424-15436	sensor-space	_
98-8	15437-15445	cortical	_
98-9	15446-15452	source	_
98-10	15453-15463	estimation	_
98-11	15464-15467	was	_
98-12	15468-15478	separately	_
98-13	15479-15488	performed	_
98-14	15489-15492	for	_
98-15	15493-15497	both	_
98-16	15498-15501	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
98-17	15502-15505	and	_
98-18	15506-15511	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
98-19	15512-15520	datasets	_
98-20	15521-15523	by	_
98-21	15524-15529	using	_
98-22	15530-15533	the	_
98-23	15534-15545	eConnectome	_
98-24	15546-15553	toolbox	_
98-25	15554-15555	(	_
98-26	15556-15560	http	_
98-27	15561-15562	:	_
98-28	15563-15585	//econnectome.umn.edu/	_
98-29	15586-15587	)	_
98-30	15588-15591	and	_
98-31	15592-15595	the	_
98-32	15596-15604	NIRS-SPM	_
98-33	15605-15612	toolbox	_
98-34	15613-15614	(	_
98-35	15615-15619	http	_
98-36	15620-15621	:	_
98-37	15622-15654	//bispl.weebly.com/nirs-spm.html	_
98-38	15655-15656	#	_
98-39	15657-15658	/	_
98-40	15659-15660	)	_
98-41	15661-15662	,	_
98-42	15663-15675	respectively	_
98-43	15676-15677	,	_
98-44	15678-15680	to	_
98-45	15681-15689	visually	_
98-46	15690-15694	scan	_
98-47	15695-15702	through	_
98-48	15703-15713	activation	_
98-49	15714-15723	locations	_
98-50	15724-15725	.	_

Text=The activation pattern of the fused EEG and fNIRS component estimated by mSPoC method was then visualized by using BrainNet Viewer (https: //www.nitrc.org/projects/bnv).
99-1	15726-15729	The	_
99-2	15730-15740	activation	_
99-3	15741-15748	pattern	_
99-4	15749-15751	of	_
99-5	15752-15755	the	_
99-6	15756-15761	fused	_
99-7	15762-15765	EEG	http://maven.renci.org/NeuroBridge/neurobridge#Electroencephalogram
99-8	15766-15769	and	_
99-9	15770-15775	fNIRS	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalNearInfraredSpectroscopy
99-10	15776-15785	component	_
99-11	15786-15795	estimated	_
99-12	15796-15798	by	_
99-13	15799-15804	mSPoC	_
99-14	15805-15811	method	_
99-15	15812-15815	was	_
99-16	15816-15820	then	_
99-17	15821-15831	visualized	_
99-18	15832-15834	by	_
99-19	15835-15840	using	_
99-20	15841-15849	BrainNet	_
99-21	15850-15856	Viewer	_
99-22	15857-15858	(	_
99-23	15859-15864	https	_
99-24	15865-15866	:	_
99-25	15867-15895	//www.nitrc.org/projects/bnv	_
99-26	15896-15897	)	_
99-27	15898-15899	.	_

Text=Statistical analysis Statistical analyses were performed using SPSS (IBM SPSS Statistics, version 22, Armonk, NY).
100-1	15900-15911	Statistical	_
100-2	15912-15920	analysis	_
100-3	15921-15932	Statistical	_
100-4	15933-15941	analyses	_
100-5	15942-15946	were	_
100-6	15947-15956	performed	_
100-7	15957-15962	using	_
100-8	15963-15967	SPSS	_
100-9	15968-15969	(	_
100-10	15970-15973	IBM	_
100-11	15974-15978	SPSS	_
100-12	15979-15989	Statistics	_
100-13	15990-15991	,	_
100-14	15992-15999	version	_
100-15	16000-16002	22	_
100-16	16003-16004	,	_
100-17	16005-16011	Armonk	_
100-18	16012-16013	,	_
100-19	16014-16016	NY	_
100-20	16017-16018	)	_
100-21	16019-16020	.	_

Text=Group differences in demographic and ROI data were investigated using two-sample t test and Bonferroni correction.
101-1	16021-16026	Group	_
101-2	16027-16038	differences	_
101-3	16039-16041	in	_
101-4	16042-16053	demographic	_
101-5	16054-16057	and	_
101-6	16058-16061	ROI	_
101-7	16062-16066	data	_
101-8	16067-16071	were	_
101-9	16072-16084	investigated	_
101-10	16085-16090	using	_
101-11	16091-16101	two-sample	_
101-12	16102-16103	t	_
101-13	16104-16108	test	_
101-14	16109-16112	and	_
101-15	16113-16123	Bonferroni	_
101-16	16124-16134	correction	_
101-17	16135-16136	.	_

Text=Statistical permutation test was performed throughout the study for connectivity analysis and machine learning method to determine group difference between two means in which the null distribution of test statistic was obtained by a number of random rearrangements for each study group (i.e., permutations).
102-1	16137-16148	Statistical	_
102-2	16149-16160	permutation	_
102-3	16161-16165	test	_
102-4	16166-16169	was	_
102-5	16170-16179	performed	_
102-6	16180-16190	throughout	_
102-7	16191-16194	the	_
102-8	16195-16200	study	_
102-9	16201-16204	for	_
102-10	16205-16217	connectivity	_
102-11	16218-16226	analysis	_
102-12	16227-16230	and	_
102-13	16231-16238	machine	_
102-14	16239-16247	learning	_
102-15	16248-16254	method	_
102-16	16255-16257	to	_
102-17	16258-16267	determine	_
102-18	16268-16273	group	_
102-19	16274-16284	difference	_
102-20	16285-16292	between	_
102-21	16293-16296	two	_
102-22	16297-16302	means	_
102-23	16303-16305	in	_
102-24	16306-16311	which	_
102-25	16312-16315	the	_
102-26	16316-16320	null	_
102-27	16321-16333	distribution	_
102-28	16334-16336	of	_
102-29	16337-16341	test	_
102-30	16342-16351	statistic	_
102-31	16352-16355	was	_
102-32	16356-16364	obtained	_
102-33	16365-16367	by	_
102-34	16368-16369	a	_
102-35	16370-16376	number	_
102-36	16377-16379	of	_
102-37	16380-16386	random	_
102-38	16387-16401	rearrangements	_
102-39	16402-16405	for	_
102-40	16406-16410	each	_
102-41	16411-16416	study	_
102-42	16417-16422	group	_
102-43	16423-16424	(	_
102-44	16425-16429	i.e.	_
102-45	16430-16431	,	_
102-46	16432-16444	permutations	_
102-47	16445-16446	)	_
102-48	16447-16448	.	_

Text=It worked as follows.
103-1	16449-16451	It	_
103-2	16452-16458	worked	_
103-3	16459-16461	as	_
103-4	16462-16469	follows	_
103-5	16470-16471	.	_

Text=First, a t-test was performed at p <0.05 significance level (uncorrected for multiplicity) to give an initial approximation to the study of statistical differences between the HD and control groups.
104-1	16472-16477	First	_
104-2	16478-16479	,	_
104-3	16480-16481	a	_
104-4	16482-16488	t-test	_
104-5	16489-16492	was	_
104-6	16493-16502	performed	_
104-7	16503-16505	at	_
104-8	16506-16507	p	_
104-9	16508-16509	<	_
104-10	16510-16514	0.05	_
104-11	16515-16527	significance	_
104-12	16528-16533	level	_
104-13	16534-16535	(	_
104-14	16536-16547	uncorrected	_
104-15	16548-16551	for	_
104-16	16552-16564	multiplicity	_
104-17	16565-16566	)	_
104-18	16567-16569	to	_
104-19	16570-16574	give	_
104-20	16575-16577	an	_
104-21	16578-16585	initial	_
104-22	16586-16599	approximation	_
104-23	16600-16602	to	_
104-24	16603-16606	the	_
104-25	16607-16612	study	_
104-26	16613-16615	of	_
104-27	16616-16627	statistical	_
104-28	16628-16639	differences	_
104-29	16640-16647	between	_
104-30	16648-16651	the	_
104-31	16652-16654	HD	_
104-32	16655-16658	and	_
104-33	16659-16666	control	_
104-34	16667-16673	groups	_
104-35	16674-16675	.	_

Text=Second, each subject was randomly reassigned to either a patient or a control group, thereby forming a division that was no longer faithful to the original real partition of the data sets.
105-1	16676-16682	Second	_
105-2	16683-16684	,	_
105-3	16685-16689	each	_
105-4	16690-16697	subject	_
105-5	16698-16701	was	_
105-6	16702-16710	randomly	_
105-7	16711-16721	reassigned	_
105-8	16722-16724	to	_
105-9	16725-16731	either	_
105-10	16732-16733	a	_
105-11	16734-16741	patient	_
105-12	16742-16744	or	_
105-13	16745-16746	a	_
105-14	16747-16754	control	_
105-15	16755-16760	group	_
105-16	16761-16762	,	_
105-17	16763-16770	thereby	_
105-18	16771-16778	forming	_
105-19	16779-16780	a	_
105-20	16781-16789	division	_
105-21	16790-16794	that	_
105-22	16795-16798	was	_
105-23	16799-16801	no	_
105-24	16802-16808	longer	_
105-25	16809-16817	faithful	_
105-26	16818-16820	to	_
105-27	16821-16824	the	_
105-28	16825-16833	original	_
105-29	16834-16838	real	_
105-30	16839-16848	partition	_
105-31	16849-16851	of	_
105-32	16852-16855	the	_
105-33	16856-16860	data	_
105-34	16861-16865	sets	_
105-35	16866-16867	.	_

Text=The procedure was repeated 1,000 times.
106-1	16868-16871	The	_
106-2	16872-16881	procedure	_
106-3	16882-16885	was	_
106-4	16886-16894	repeated	_
106-5	16895-16900	1,000	_
106-6	16901-16906	times	_
106-7	16907-16908	.	_

Text=The t-values were recalculated, and the null distribution of test statistics for the group difference was obtained.
107-1	16909-16912	The	_
107-2	16913-16921	t-values	_
107-3	16922-16926	were	_
107-4	16927-16939	recalculated	_
107-5	16940-16941	,	_
107-6	16942-16945	and	_
107-7	16946-16949	the	_
107-8	16950-16954	null	_
107-9	16955-16967	distribution	_
107-10	16968-16970	of	_
107-11	16971-16975	test	_
107-12	16976-16986	statistics	_
107-13	16987-16990	for	_
107-14	16991-16994	the	_
107-15	16995-17000	group	_
107-16	17001-17011	difference	_
107-17	17012-17015	was	_
107-18	17016-17024	obtained	_
107-19	17025-17026	.	_

Text=Finally, the proportion of sampled permutations where the t-values were larger than the observed test statistics was computed as the p-value of the observed group difference.
108-1	17027-17034	Finally	_
108-2	17035-17036	,	_
108-3	17037-17040	the	_
108-4	17041-17051	proportion	_
108-5	17052-17054	of	_
108-6	17055-17062	sampled	_
108-7	17063-17075	permutations	_
108-8	17076-17081	where	_
108-9	17082-17085	the	_
108-10	17086-17094	t-values	_
108-11	17095-17099	were	_
108-12	17100-17106	larger	_
108-13	17107-17111	than	_
108-14	17112-17115	the	_
108-15	17116-17124	observed	_
108-16	17125-17129	test	_
108-17	17130-17140	statistics	_
108-18	17141-17144	was	_
108-19	17145-17153	computed	_
108-20	17154-17156	as	_
108-21	17157-17160	the	_
108-22	17161-17168	p-value	_
108-23	17169-17171	of	_
108-24	17172-17175	the	_
108-25	17176-17184	observed	_
108-26	17185-17190	group	_
108-27	17191-17201	difference	_
108-28	17202-17203	.	_

Text=Similarly in mSPoC analysis, permutation was performed to randomize the initial set of EEG-signal spatial filters until a suitable convergence criterion was met in order to optimize the fusion objective.
109-1	17204-17213	Similarly	_
109-2	17214-17216	in	_
109-3	17217-17222	mSPoC	_
109-4	17223-17231	analysis	_
109-5	17232-17233	,	_
109-6	17234-17245	permutation	_
109-7	17246-17249	was	_
109-8	17250-17259	performed	_
109-9	17260-17262	to	_
109-10	17263-17272	randomize	_
109-11	17273-17276	the	_
109-12	17277-17284	initial	_
109-13	17285-17288	set	_
109-14	17289-17291	of	_
109-15	17292-17302	EEG-signal	_
109-16	17303-17310	spatial	_
109-17	17311-17318	filters	_
109-18	17319-17324	until	_
109-19	17325-17326	a	_
109-20	17327-17335	suitable	_
109-21	17336-17347	convergence	_
109-22	17348-17357	criterion	_
109-23	17358-17361	was	_
109-24	17362-17365	met	_
109-25	17366-17368	in	_
109-26	17369-17374	order	_
109-27	17375-17377	to	_
109-28	17378-17386	optimize	_
109-29	17387-17390	the	_
109-30	17391-17397	fusion	_
109-31	17398-17407	objective	_
109-32	17408-17409	.	_

Text=A level of significance was set p <0.05 (uncorrected), and subject ’ s age, gender, IQ were defined as covariates to minimize potential biases to the results.
110-1	17410-17411	A	_
110-2	17412-17417	level	_
110-3	17418-17420	of	_
110-4	17421-17433	significance	_
110-5	17434-17437	was	_
110-6	17438-17441	set	_
110-7	17442-17443	p	_
110-8	17444-17445	<	_
110-9	17446-17450	0.05	_
110-10	17451-17452	(	_
110-11	17453-17464	uncorrected	_
110-12	17465-17466	)	_
110-13	17467-17468	,	_
110-14	17469-17472	and	_
110-15	17473-17480	subject	_
110-16	17481-17482	’	_
110-17	17483-17484	s	_
110-18	17485-17488	age	_
110-19	17489-17490	,	_
110-20	17491-17497	gender	_
110-21	17498-17499	,	_
110-22	17500-17502	IQ	_
110-23	17503-17507	were	_
110-24	17508-17515	defined	_
110-25	17516-17518	as	_
110-26	17519-17529	covariates	_
110-27	17530-17532	to	_
110-28	17533-17541	minimize	_
110-29	17542-17551	potential	_
110-30	17552-17558	biases	_
110-31	17559-17561	to	_
110-32	17562-17565	the	_
110-33	17566-17573	results	_
110-34	17574-17575	.	_

Text=Due to the small sample size of the study, we used the current alternative strategy for convention, in which the matched sample size was appropriately adapted to the cost concerns of the study.
111-1	17576-17579	Due	_
111-2	17580-17582	to	_
111-3	17583-17586	the	_
111-4	17587-17592	small	_
111-5	17593-17599	sample	_
111-6	17600-17604	size	_
111-7	17605-17607	of	_
111-8	17608-17611	the	_
111-9	17612-17617	study	_
111-10	17618-17619	,	_
111-11	17620-17622	we	_
111-12	17623-17627	used	_
111-13	17628-17631	the	_
111-14	17632-17639	current	_
111-15	17640-17651	alternative	_
111-16	17652-17660	strategy	_
111-17	17661-17664	for	_
111-18	17665-17675	convention	_
111-19	17676-17677	,	_
111-20	17678-17680	in	_
111-21	17681-17686	which	_
111-22	17687-17690	the	_
111-23	17691-17698	matched	_
111-24	17699-17705	sample	_
111-25	17706-17710	size	_
111-26	17711-17714	was	_
111-27	17715-17728	appropriately	_
111-28	17729-17736	adapted	_
111-29	17737-17739	to	_
111-30	17740-17743	the	_
111-31	17744-17748	cost	_
111-32	17749-17757	concerns	_
111-33	17758-17760	of	_
111-34	17761-17764	the	_
111-35	17765-17770	study	_
111-36	17771-17772	.	_

Text=All p values were two-tailed (α = 0.05).
112-1	17773-17776	All	_
112-2	17777-17778	p	_
112-3	17779-17785	values	_
112-4	17786-17790	were	_
112-5	17791-17801	two-tailed	_
112-6	17802-17803	(	_
112-7	17804-17805	α	_
112-8	17806-17807	=	_
112-9	17808-17812	0.05	_
112-10	17813-17814	)	_
112-11	17815-17816	.	_

Text=MATLAB (MathWorks, Inc., Natick, MA, USA) was used for all computations.
113-1	17817-17823	MATLAB	_
113-2	17824-17825	(	_
113-3	17826-17835	MathWorks	_
113-4	17836-17837	,	_
113-5	17838-17842	Inc.	_
113-6	17843-17844	,	_
113-7	17845-17851	Natick	_
113-8	17852-17853	,	_
113-9	17854-17856	MA	_
113-10	17857-17858	,	_
113-11	17859-17862	USA	_
113-12	17863-17864	)	_
113-13	17865-17868	was	_
113-14	17869-17873	used	_
113-15	17874-17877	for	_
113-16	17878-17881	all	_
113-17	17882-17894	computations	_
113-18	17895-17896	.	_

